Association counts use unique genes with 01-High Priority evidence and unique cells in the authored Specific tier (not the IC-score significance threshold). Reverse counts list meta traits and individual traits separately; these are overlapping levels of evidence, not independent totals. Counts cover the full available catalogue, not the displayed rows or sampled UMAP. Unavailable profiles are excluded from reverse counts; a dash means unavailable or an ambiguous identity, not zero. The browser initially shows 50 rows; choose Rows to change this. Complete rows remain in the HTML, and ordinary page links expose any continuation pages for AI readers and crawlers.
ASPC.activated: Meta traits
How association tiers are defined — cell–trait and gene–trait
SCREATE tier definitions supplied by the atlas curator. This methods note explains the prepared classifications; it does not recompute or change any report scores or tiers.
Cell–trait tiers
- Cell–trait links
- Identify cell types whose regulatory activity is associated with a trait’s genetic signal.
- Required for Specific or Relevant
- The ICE-CREAM score derived from the mean metacell Z score must be ≥ 5.39, with BOTH nominal and adjusted ICE-CREAM P values ≤ 0.05.
- Specific (Tier 1)
- Also meets all cell-set enrichment analysis (CSEA) criteria in at least one tested comparison: nominal P ≤ 0.05 AND adjusted P ≤ 0.05 AND normalized enrichment score (NES) ≥ 1, all in that comparison. This indicates that trait-associated activity is concentrated in this cell type relative to the tested background.
- Relevant (Tier 2)
- Meets the ICE-CREAM requirements but not the additional CSEA criteria. The cell type may share trait-associated activity with other cell types.
- Interpretation and report values
- CSEA is cell-set enrichment analysis, analogous to gene-set enrichment analysis but using sets of cells along a ranked list of ICE-CREAM scores. The eligibility score derived from the mean metacell Z score is not the displayed mean IC score. Do not infer a tier from the displayed mean, its descriptive Significance column, or a single CSEA summary value. Reports preserve prepared tiers; Other means an available association outside Specific/Relevant, and unavailable is not zero or proof of biological irrelevance.
- Meta traits and individual traits
- Use the prepared tier for the exact meta trait or individual trait. A meta trait’s Best child CSEA FDR is the lowest available child FDR, not a combined or meta-trait significance test. Its displayed mean child NES is descriptive, not a new CSEA test. These summaries must not be used to reconstruct or override the meta-trait tier.
Gene–trait priorities (variant–tCRE–gene evidence)
- Variant–tCRE–gene links
- Candidate variants connect to genes through overlapping promoters or distal transcribed cis-regulatory elements (tCREs) linked to gene promoters by the Activity-by-Contact (ABC) model.
- Required genetic support
- The variant belongs to a purity-passing SuSiE credible set OR qualifies for Borzoi rescue. Borzoi rescue requires BOTH a variant-causality score ≥ 0.3 AND linkage disequilibrium with the lead variant of r² ≥ 0.2.
- Required cellular support
- The overlapping promoter has positive tCRE activity OR the distal element has a passing cell-specific ABC link to the gene, in a Specific or Relevant cell subtype (L1S) or fine-grained state (L2). BOTH genetic and cellular support are required for High or Medium priority.
- High priority
- Among records meeting both minimum requirements, High requires a genetic score ≥ 0.5 AND a Layer 1 correlation > 0.3 between tCRE activity and the trait’s cellular profile across cell subtypes.
- Medium priority
- Meets both minimum requirements but not one or both additional High thresholds. The genetic score is the higher of the SuSiE posterior inclusion probability (PIP) and the Borzoi variant-causality score.
- Same-record evidence and aggregation
- Each priority requires genetic and cellular evidence supporting the SAME variant–tCRE–gene record. Do not combine thresholds or evidence from different records to create a qualifying link. A gene receives the highest priority observed among its supporting records. A tCRE summary uses supporting records for that exact tCRE, not every trait of its linked genes. Separately displayed aggregate scores do not relax the same-record rule.
- Limits of interpretation
- A priority is candidate-association evidence, not proof of a causal variant, causal gene, causal cell type or treatment efficacy. Missing evidence is unavailable, not zero. MAGMA −log10(P), displayed credibility scores, cellular-context scores and G/C tier codes must not be substituted for these eligibility tests; use the provided records and their documented fields.
State · 4,466 full-atlas cells · all tissues.
Marker genes and cell annotation · Open this population in Cell Browser →
ICE-CREAM (IC) is −log10(P) from a permutation test. An IC score of 3 corresponds to an unadjusted P value of 0.001; 5.5 is the multiple-testing-corrected significance threshold across all metacells. The Significance categories are Significant for IC > 5.5, Nominal for 3 ≤ IC ≤ 5.5, and Nonsignificant for IC < 3. These reports display mean IC scores across full-atlas populations, not the UMAP sample. The categories apply to the displayed scores: a cell-group mean or an average across individual traits is descriptive and is not itself a newly tested P value or a new multiple-testing correction. All scores are retained. Enrichment is not proof of causality or treatment efficacy.
Rows 1–1,000 of 5,288; ranked by score descending. Equal values use name/identifier order.
| Browsers | # | Trait | Trait code | Mean IC score | Category | Main cell contexts | Genes (High Priority) | L1 cells (Specific) | L1S cells (Specific) | L2 cells (Specific) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Hip index | BMORP000012 | 49.71 | Body morphology | Adipose | 121 | 3 | 4 | 14 | |
| 2 | CBLN4 levels | PROLV000272 | 41.66 | Protein levels | Adipose | 11 | 2 | 8 | 9 | |
| 3 | Nerve entrapment syndrome | NEURO000028 | 41.28 | Neurologic | Stromal / connective | 19 | 4 | 7 | 12 | |
| 4 | TNC/VCAM1 ratio | PRORT001843 | 40.45 | Protein ratios | Adipose | 38 | 3 | 10 | 13 | |
| 5 | CLMP/PIK3IP1 ratio | PRORT000669 | 39.13 | Protein ratios | Adipose | 1 | 3 | 6 | 10 | |
| 6 | COL6A3/CST3 ratio | PRORT000696 | 38.65 | Protein ratios | Adipose | 33 | 3 | 8 | 18 | |
| 7 | DLK1/FAP ratio | PRORT000911 | 37.85 | Protein ratios | Adipose | 26 | 4 | 8 | 25 | |
| 8 | BOC levels | PROLV000207 | 36.90 | Protein levels | Stromal / connective | 7 | 5 | 15 | 42 | |
| 9 | ROBO2/SCARF2 ratio | PRORT001745 | 36.57 | Protein ratios | Adipose | 12 | 4 | 10 | 12 | |
| 10 | A body shape index, ABSI | BMORP000001 | 34.68 | Body morphology | Stromal / connective | 203 | 3 | 6 | 12 | |
| 11 | Operation, hernia | GASTR000040 | 34.48 | Gastrointestinal | Adipose | 21 | 2 | 5 | 9 | |
| 12 | HSPG2/IGFBP6 ratio | PRORT001307 | 34.27 | Protein ratios | Adipose | 15 | 3 | 9 | 18 | |
| 13 | Waist-hip ratio | BMORP000014 | 34.09 | Body morphology | Adipose | 523 | 3 | 5 | 10 | |
| 14 | ROBO2 levels | PROLV001750 | 33.33 | Protein levels | Adipose | 69 | 5 | 10 | 24 | |
| 15 | COL4A1 levels | PROLV000490 | 32.05 | Protein levels | Hepatocyte | 117 | 3 | 10 | 16 | |
| 16 | Waist circumference, adjusted for BMI | BMORP000006 | 31.66 | Body morphology | Stromal / connective | 314 | 3 | 3 | 9 | |
| 17 | EGFR/FAP ratio | PRORT001000 | 31.37 | Protein ratios | Adipose | 52 | 4 | 8 | 17 | |
| 18 | COL6A3/COLEC12 ratio | PRORT000695 | 30.80 | Protein ratios | Adipose | 53 | 4 | 9 | 18 | |
| 19 | Heel quantitative ultrasound | MSKEL000005 | 30.73 | Musculoskeletal | Stromal / connective | 361 | 3 | 8 | 12 | |
| 20 | IGFBP6/SMOC2 ratio | PRORT001338 | 29.95 | Protein ratios | Adipose | 2 | 3 | 8 | 13 | |
| 21 | Bone fragility disorder | MSKEL000007 | 28.77 | Musculoskeletal | Adipose | 23 | 5 | 15 | 25 | |
| 22 | Medication, macular degeneration | OPHTH000015 | 28.25 | Ophthalmic | Hepatocyte | 41 | 3 | 11 | 20 | |
| 23 | Hyperthyroidism, subclinical in pregnancy | ENDOC000011 | 27.60 | Endocrine | Adipose | 1 | 3 | 9 | 14 | |
| 24 | Intraocular pressure | OPHTH000011 | 26.79 | Ophthalmic | Stromal / connective | 184 | 4 | 6 | 10 | |
| 25 | Arm impedance | BCOMP000013 | 26.45 | Body composition | Stromal / connective | 665 | 4 | 6 | 12 | |
| 26 | ZNRF4 levels | PROLV002214 | 25.14 | Protein levels | Adipose | 7 | 5 | 11 | 14 | |
| 27 | Bone mineral density | MSKEL000004 | 24.81 | Musculoskeletal | Stromal / connective | 350 | 3 | 8 | 10 | |
| 28 | RET levels | PROLV001724 | 24.68 | Protein levels | Stromal / connective | 18 | 5 | 10 | 21 | |
| 29 | TNC levels | PROLV002052 | 24.43 | Protein levels | Adipose | 35 | 2 | 6 | 11 | |
| 30 | Corneal properties | OPHTH000010 | 24.32 | Ophthalmic | Stromal / connective | 279 | 3 | 5 | 10 | |
| 31 | PTPRH levels | PROLV001676 | 24.22 | Protein levels | Vascular | 69 | 3 | 7 | 15 | |
| 32 | COL6A3/SMOC2 ratio | PRORT000700 | 24.20 | Protein ratios | Adipose | 34 | 4 | 6 | 17 | |
| 33 | VCAN levels | PROLV002156 | 23.44 | Protein levels | Adipose | 116 | 3 | 8 | 21 | |
| 34 | FAP levels | PROLV000769 | 23.05 | Protein levels | Adipose | 78 | 7 | 12 | 27 | |
| 35 | ENG levels | PROLV000704 | 22.75 | Protein levels | Adipose | 10 | 4 | 12 | 30 | |
| 36 | SCARA5 levels | PROLV001780 | 22.65 | Protein levels | Stromal / connective | 8 | 2 | 4 | 9 | |
| 37 | HEG1 levels | PROLV000961 | 22.50 | Protein levels | Vascular | 51 | 3 | 7 | 16 | |
| 38 | Coronary artery calcification | VASCU000055 | 22.41 | Vascular | Vascular | 56 | 4 | 6 | 11 | |
| 39 | BPIFB1/GLRX ratio | PRORT000245 | 21.56 | Protein ratios | Adipose | 0 | 4 | 9 | 18 | |
| 40 | Coronary artery plaque burden | VASCU000056 | 21.49 | Vascular | Vascular | 37 | 3 | 5 | 9 | |
| 41 | Hernia | GASTR000008 | 21.26 | Gastrointestinal | Stromal / connective | 183 | 2 | 4 | 8 | |
| 42 | EGFR levels | PROLV000687 | 21.19 | Protein levels | Adipose | 22 | 3 | 10 | 13 | |
| 43 | CST3/TFF3 ratio | PRORT000788 | 20.92 | Protein ratios | Adipose | 7 | 1 | 9 | 12 | |
| 44 | MAMDC2 levels | PROLV001258 | 20.32 | Protein levels | Stromal / connective | 36 | 5 | 8 | 14 | |
| 45 | Prolapse, pelvic organ | REPRO000025 | 19.25 | Reproductive | Stromal / connective | 35 | 3 | 6 | 13 | |
| 46 | Ankle spacing width | MSKEL000056 | 19.16 | Musculoskeletal | Stromal / connective | 338 | 2 | 5 | 6 | |
| 47 | Blood pressure, BP, pulse | VASCU000010 | 18.97 | Vascular | Stromal / connective | 1,008 | 5 | 7 | 16 | |
| 48 | Leukoencephalopathy | NEURO000004 | 18.74 | Neurologic | Stromal / connective | 2 | 2 | 10 | 7 | |
| 49 | Medication, antiglaucoma | OPHTH000014 | 18.66 | Ophthalmic | Stromal / connective | 69 | 2 | 5 | 12 | |
| 50 | Whole body impedance | BCOMP000007 | 18.61 | Body composition | Stromal / connective | 553 | 5 | 7 | 15 | |
| 51 | GSTA4 levels | PROLV000941 | 18.39 | Protein levels | Adipose | 0 | 2 | 16 | 26 | |
| 52 | CTSD/PRCP ratio | PRORT000799 | 18.26 | Protein ratios | Hepatocyte | 16 | 2 | 10 | 21 | |
| 53 | ERBB3 levels | PROLV000725 | 18.26 | Protein levels | Hepatocyte | 97 | 4 | 10 | 20 | |
| 54 | CD200R1 levels | PROLV000317 | 18.24 | Protein levels | Adipose | 54 | 2 | 5 | 14 | |
| 55 | Hip circumference, adjusted for BMI | BMORP000005 | 18.05 | Body morphology | Stromal / connective | 326 | 5 | 6 | 10 | |
| 56 | BCAN/DPP6 ratio | PRORT000215 | 17.95 | Protein ratios | Stromal / connective | 0 | 5 | 11 | 20 | |
| 57 | PSPN levels | PROLV001661 | 17.77 | Protein levels | Stromal / connective | 26 | 4 | 9 | 11 | |
| 58 | Medication, antithrombotic | VASCU000033 | 17.59 | Vascular | Vascular | 37 | 4 | 10 | 12 | |
| 59 | CDON/SCARA5 ratio | PRORT000581 | 17.47 | Protein ratios | Adipose | 51 | 3 | 7 | 11 | |
| 60 | ICAM2 levels | PROLV001005 | 17.33 | Protein levels | Vascular | 38 | 4 | 7 | 20 | |
| 61 | Leg impedance | BCOMP000016 | 17.27 | Body composition | Stromal / connective | 562 | 4 | 7 | 19 | |
| 62 | Spinal deformity | MSKEL000077 | 17.24 | Musculoskeletal | Stromal / connective | 0 | 2 | 5 | 13 | |
| 63 | COL6A3/OGN ratio | PRORT000699 | 17.20 | Protein ratios | Adipose | 33 | 5 | 8 | 16 | |
| 64 | HSPG2/SMOC2 ratio | PRORT001309 | 17.17 | Protein ratios | Stromal / connective | 32 | 4 | 9 | 16 | |
| 65 | Lean mass | BCOMP000009 | 17.14 | Body composition | Stromal / connective | 897 | 4 | 7 | 8 | |
| 66 | SRPX levels | PROLV001945 | 16.94 | Protein levels | Adipose | 32 | 4 | 10 | 16 | |
| 67 | TNXB levels | PROLV002085 | 16.86 | Protein levels | Stromal / connective | 56 | 4 | 7 | 22 | |
| 68 | CNTN1 levels | PROLV000475 | 16.77 | Protein levels | Stromal / connective | 121 | 4 | 10 | 25 | |
| 69 | Pelvic morphology | BMORP000021 | 16.75 | Body morphology | Stromal / connective | 54 | 3 | 5 | 6 | |
| 70 | PILRA/TNFRSF1A ratio | PRORT001668 | 16.74 | Protein ratios | Adipose | 42 | 2 | 9 | 13 | |
| 71 | FCRL2/TNFRSF13B ratio | PRORT001132 | 16.55 | Protein ratios | B / plasma cell | 10 | 3 | 8 | 18 | |
| 72 | CCN3/FAP ratio | PRORT000373 | 16.38 | Protein ratios | Hepatocyte | 27 | 4 | 11 | 24 | |
| 73 | ACVRL1/TNFRSF19 ratio | PRORT000017 | 16.30 | Protein ratios | Vascular | 20 | 2 | 7 | 15 | |
| 74 | Body proportion | BMORP000019 | 16.28 | Body morphology | Stromal / connective | 71 | 3 | 8 | 8 | |
| 75 | Gut microbial abundance, Olsenella C | GASTR000030 | 16.24 | Gastrointestinal | Vascular | 0 | 4 | 10 | 24 | |
| 76 | COL6A3/TAFA5 ratio | PRORT000702 | 16.17 | Protein ratios | Hepatocyte | 31 | 5 | 7 | 24 | |
| 77 | CASP1 levels | PROLV000265 | 16.03 | Protein levels | Myeloid | 55 | 2 | 10 | 18 | |
| 78 | Medication, post-myocardial infarction | CARDI000045 | 15.92 | Cardiac | Vascular | 76 | 4 | 9 | 11 | |
| 79 | ST6GALNAC2 levels | PROLV001954 | 15.91 | Protein levels | Neural / glial | 11 | 3 | 8 | 11 | |
| 80 | VWF levels | PROLV002182 | 15.89 | Protein levels | Vascular | 12 | 2 | 5 | 13 | |
| 81 | Consultant specialty, ophthalmology | MISCL000018 | 15.83 | Miscellaneous | Vascular | 0 | 4 | 12 | 22 | |
| 82 | FUT8/TNFSF14 ratio | PRORT001192 | 15.70 | Protein ratios | Adipose | 13 | 4 | 22 | 56 | |
| 83 | PSME2/RBKS ratio | PRORT001713 | 15.68 | Protein ratios | Hepatocyte | 23 | 4 | 15 | 13 | |
| 84 | RFC4 levels | PROLV001726 | 15.51 | Protein levels | Stromal / connective | 1 | 4 | 14 | 19 | |
| 85 | MATN2 levels | PROLV001277 | 15.49 | Protein levels | Stromal / connective | 78 | 3 | 6 | 14 | |
| 86 | Aortic valve disease | CARDI000053 | 15.28 | Cardiac | Vascular | 83 | 5 | 9 | 17 | |
| 87 | EFEMP1/TGFBR3 ratio | PRORT000988 | 14.98 | Protein ratios | Stromal / connective | 5 | 3 | 7 | 15 | |
| 88 | CD300LG/DSG2 ratio | PRORT000435 | 14.89 | Protein ratios | Vascular | 16 | 1 | 5 | 9 | |
| 89 | COL6A3/HSPG2 ratio | PRORT000697 | 14.68 | Protein ratios | Stromal / connective | 49 | 3 | 7 | 15 | |
| 90 | ENPP7 levels | PROLV000711 | 14.55 | Protein levels | Hepatocyte | 60 | 2 | 10 | 22 | |
| 91 | Heart failure, with coronary heart disease | CARDI000005 | 14.47 | Cardiac | Stromal / connective | 54 | 3 | 9 | 17 | |
| 92 | SCAMP3/VPS53 ratio | PRORT001757 | 14.43 | Protein ratios | Vascular | 0 | 2 | 9 | 19 | |
| 93 | PKD1 levels | PROLV001564 | 14.40 | Protein levels | Vascular | 84 | 4 | 11 | 19 | |
| 94 | DPP6 levels | PROLV000647 | 14.32 | Protein levels | Myeloid | 131 | 3 | 11 | 15 | |
| 95 | ADAMTS13 levels | PROLV000031 | 14.28 | Protein levels | Hepatocyte | 161 | 2 | 10 | 17 | |
| 96 | SCARA5/TNC ratio | PRORT001760 | 14.10 | Protein ratios | Granulosa cell | 39 | 2 | 9 | 13 | |
| 97 | Corneal keratometry | OPHTH000006 | 13.98 | Ophthalmic | Stromal / connective | 298 | 3 | 5 | 8 | |
| 98 | Tympanic membrane perforation | AUDIO000019 | 13.89 | Auditory | Stromal / connective | 5 | 3 | 6 | 8 | |
| 99 | PATE4 levels | PROLV001498 | 13.87 | Protein levels | Muscle / cardiac | 0 | 2 | 9 | 19 | |
| 100 | Haemorrhoidal disease | VASCU000062 | 13.77 | Vascular | Vascular | 67 | 4 | 9 | 16 | |
| 101 | CD34 levels | PROLV000336 | 13.75 | Protein levels | Stromal / connective | 67 | 3 | 10 | 21 | |
| 102 | IFNGR1/THBD ratio | PRORT001332 | 13.68 | Protein ratios | Vascular | 22 | 3 | 9 | 14 | |
| 103 | CDH5/ENG ratio | PRORT000556 | 13.66 | Protein ratios | Vascular | 30 | 2 | 8 | 14 | |
| 104 | SLITRK6 levels | PROLV001890 | 13.63 | Protein levels | Adipose | 4 | 2 | 11 | 17 | |
| 105 | CR2/TNFRSF13B ratio | PRORT000738 | 13.54 | Protein ratios | B / plasma cell | 32 | 3 | 9 | 15 | |
| 106 | LAMB1 levels | PROLV001179 | 13.46 | Protein levels | Stromal / connective | 44 | 2 | 9 | 22 | |
| 107 | DNAJA2/PLXNA4 ratio | PRORT000923 | 13.39 | Protein ratios | Lymphocyte | 20 | 6 | 17 | 40 | |
| 108 | C7 levels | PROLV000236 | 13.33 | Protein levels | Adipose | 12 | 2 | 11 | 27 | |
| 109 | CXCL10/WARS ratio | PRORT000815 | 13.17 | Protein ratios | Hepatocyte | 4 | 2 | 9 | 17 | |
| 110 | SERPING1 levels | PROLV001834 | 13.11 | Protein levels | Myeloid | 141 | 3 | 12 | 23 | |
| 111 | Carotid intima-media thickness | VASCU000053 | 13.07 | Vascular | Adipose | 15 | 2 | 5 | 12 | |
| 112 | Acquired foot deformities | MSKEL000052 | 12.91 | Musculoskeletal | Stromal / connective | 38 | 2 | 5 | 12 | |
| 113 | VNN2 levels | PROLV002165 | 12.82 | Protein levels | Myeloid | 72 | 2 | 11 | 14 | |
| 114 | TNFRSF14/TNFSF14 ratio | PRORT001851 | 12.81 | Protein ratios | Hepatocyte | 14 | 3 | 15 | 47 | |
| 115 | PTPRF/PTPRS ratio | PRORT001721 | 12.81 | Protein ratios | Hepatocyte | 76 | 4 | 11 | 24 | |
| 116 | ADGRB3 levels | PROLV000040 | 12.79 | Protein levels | Stromal / connective | 34 | 5 | 8 | 25 | |
| 117 | CTSO/IGF2R ratio | PRORT000803 | 12.66 | Protein ratios | Hepatocyte | 20 | 4 | 13 | 26 | |
| 118 | AIFM1/EGF ratio | PRORT000059 | 12.64 | Protein ratios | Hepatocyte | 15 | 2 | 10 | 20 | |
| 119 | CDH5 levels | PROLV000376 | 12.60 | Protein levels | Vascular | 33 | 3 | 9 | 25 | |
| 120 | LTBP2 levels | PROLV001242 | 12.59 | Protein levels | Myeloid | 145 | 4 | 14 | 23 | |
| 121 | Lens disorder | OPHTH000013 | 12.59 | Ophthalmic | Stromal / connective | 3 | 5 | 8 | 10 | |
| 122 | Hand grip strength | MSKEL000030 | 12.55 | Musculoskeletal | Stromal / connective | 131 | 5 | 7 | 13 | |
| 123 | KDR/VWF ratio | PRORT001402 | 12.52 | Protein ratios | Vascular | 8 | 2 | 7 | 14 | |
| 124 | ESR1 levels | PROLV000735 | 12.50 | Protein levels | Adipose | 0 | 3 | 13 | 27 | |
| 125 | PLXDC1 levels | PROLV001583 | 12.49 | Protein levels | Adipose | 4 | 2 | 13 | 38 | |
| 126 | NOTCH3/PTPRS ratio | PRORT001593 | 12.36 | Protein ratios | Vascular | 59 | 5 | 14 | 26 | |
| 127 | Lens replacement | OPHTH000025 | 12.33 | Ophthalmic | Vascular | 12 | 2 | 13 | 17 | |
| 128 | HGF/TNFSF14 ratio | PRORT001286 | 12.29 | Protein ratios | Hepatocyte | 19 | 5 | 14 | 27 | |
| 129 | SCARF2 levels | PROLV001783 | 12.29 | Protein levels | Adipose | 49 | 2 | 6 | 11 | |
| 130 | Mammary dysplasia | BREAS000001 | 12.26 | Breast | Adipose | 0 | 1 | 8 | 17 | |
| 131 | Atrial volume | CARDI000009 | 12.26 | Cardiac | Stromal / connective | 0 | 3 | 9 | 19 | |
| 132 | FGR levels | PROLV000804 | 12.26 | Protein levels | Adipose | 16 | 7 | 15 | 30 | |
| 133 | Osteoporosis | MSKEL000010 | 12.22 | Musculoskeletal | Stromal / connective | 5 | 3 | 5 | 21 | |
| 134 | AOC3 levels | PROLV000109 | 12.21 | Protein levels | Myeloid | 116 | 4 | 13 | 22 | |
| 135 | SFRP2 levels | PROLV001845 | 12.21 | Protein levels | Neural / glial | 11 | 4 | 8 | 24 | |
| 136 | ADGRD1 levels | PROLV000041 | 12.18 | Protein levels | Hepatocyte | 47 | 5 | 12 | 15 | |
| 137 | LEPR/NTRK2 ratio | PRORT001448 | 12.15 | Protein ratios | Neural / glial | 24 | 4 | 10 | 21 | |
| 138 | SSC5D levels | PROLV001948 | 12.14 | Protein levels | Vascular | 40 | 3 | 14 | 12 | |
| 139 | Aortic diameter | VASCU000052 | 12.08 | Vascular | Muscle / cardiac | 215 | 5 | 7 | 19 | |
| 140 | Glaucoma | OPHTH000009 | 12.04 | Ophthalmic | Stromal / connective | 407 | 3 | 7 | 9 | |
| 141 | CDON levels | PROLV000385 | 11.96 | Protein levels | Granulosa cell | 4 | 5 | 10 | 14 | |
| 142 | GGH/INHBC ratio | PRORT001212 | 11.92 | Protein ratios | Hepatocyte | 39 | 2 | 10 | 25 | |
| 143 | HYOU1/THBD ratio | PRORT001318 | 11.91 | Protein ratios | Hepatocyte | 54 | 2 | 7 | 23 | |
| 144 | NRP1 levels | PROLV001434 | 11.85 | Protein levels | Hepatocyte | 128 | 2 | 10 | 21 | |
| 145 | CHI3L1/HSPG2 ratio | PRORT000610 | 11.84 | Protein ratios | Hepatocyte | 10 | 2 | 9 | 26 | |
| 146 | MSMB levels | PROLV001341 | 11.79 | Protein levels | Stromal / connective | 32 | 3 | 9 | 14 | |
| 147 | TGFBR3 levels | PROLV002023 | 11.77 | Protein levels | Adipose | 33 | 3 | 6 | 14 | |
| 148 | APOM/MCAM ratio | PRORT000119 | 11.76 | Protein ratios | Hepatocyte | 64 | 2 | 10 | 18 | |
| 149 | Height | BMORP000009 | 11.63 | Body morphology | Stromal / connective | 3,280 | 3 | 4 | 6 | |
| 150 | PSG1 levels | PROLV001656 | 11.61 | Protein levels | Myeloid | 41 | 4 | 13 | 21 | |
| 151 | CD79B/FCRL2 ratio | PRORT000511 | 11.58 | Protein ratios | Stromal / connective | 17 | 2 | 7 | 12 | |
| 152 | L1CAM levels | PROLV001171 | 11.53 | Protein levels | Vascular | 70 | 6 | 12 | 37 | |
| 153 | Retinal and choroidal disorder | OPHTH000038 | 11.44 | Ophthalmic | Stromal / connective | 74 | 4 | 9 | 18 | |
| 154 | CST6/NECTIN4 ratio | PRORT000792 | 11.36 | Protein ratios | Epithelial | 3 | 1 | 5 | 13 | |
| 155 | Operation, vascular | VASCU000058 | 11.30 | Vascular | Vascular | 116 | 4 | 7 | 10 | |
| 156 | COMP/DPP4 ratio | PRORT000709 | 11.30 | Protein ratios | Myeloid | 32 | 4 | 13 | 18 | |
| 157 | ADAMTS8 levels | PROLV000035 | 11.28 | Protein levels | Muscle / cardiac | 48 | 3 | 5 | 11 | |
| 158 | CCDC80/CCL27 ratio | PRORT000332 | 11.27 | Protein ratios | Myeloid | 40 | 3 | 6 | 28 | |
| 159 | Serine | METAB000029 | 11.27 | Metabolites | Epithelial | 1 | 4 | 13 | 17 | |
| 160 | EIF4G1/TBC1D23 ratio | PRORT001014 | 11.18 | Protein ratios | Adipose | 1 | 3 | 7 | 13 | |
| 161 | POSTN levels | PROLV001603 | 11.18 | Protein levels | Adipose | 40 | 1 | 5 | 14 | |
| 162 | Sexually transmitted infection | IMMUN000072 | 11.16 | Immunologic | Granulosa cell | 7 | 4 | 9 | 30 | |
| 163 | APOF levels | PROLV000125 | 11.12 | Protein levels | Hepatocyte | 56 | 4 | 10 | 22 | |
| 164 | Macular degeneration | OPHTH000036 | 11.11 | Ophthalmic | Hepatocyte | 106 | 2 | 7 | 15 | |
| 165 | IFIT2 levels | PROLV001016 | 11.00 | Protein levels | Myeloid | 17 | 5 | 9 | 20 | |
| 166 | NOTCH1 levels | PROLV001416 | 10.96 | Protein levels | Hepatocyte | 100 | 2 | 7 | 17 | |
| 167 | COMP/MYOC ratio | PRORT000712 | 10.81 | Protein ratios | Adipose | 3 | 4 | 14 | 23 | |
| 168 | C1QL2 levels | PROLV000223 | 10.81 | Protein levels | Vascular | 43 | 2 | 7 | 24 | |
| 169 | CLU levels | PROLV000467 | 10.73 | Protein levels | Granulosa cell | 75 | 5 | 15 | 24 | |
| 170 | HHIP levels | PROLV000969 | 10.72 | Protein levels | B / plasma cell | 0 | 3 | 9 | 16 | |
| 171 | COLEC12/TGFBR2 ratio | PRORT000707 | 10.71 | Protein ratios | Hepatocyte | 75 | 3 | 8 | 18 | |
| 172 | SIL1 levels | PROLV001866 | 10.68 | Protein levels | Stromal / connective | 1 | 4 | 14 | 21 | |
| 173 | Fibroblastic disorder | MSKEL000064 | 10.67 | Musculoskeletal | Stromal / connective | 49 | 3 | 6 | 10 | |
| 174 | DPP4/ITGB1 ratio | PRORT000944 | 10.65 | Protein ratios | Myeloid | 11 | 3 | 12 | 25 | |
| 175 | PLXDC2 levels | PROLV001584 | 10.64 | Protein levels | Granulosa cell | 18 | 4 | 16 | 23 | |
| 176 | NCR3LG1 levels | PROLV001384 | 10.59 | Protein levels | Hepatocyte | 32 | 1 | 8 | 15 | |
| 177 | CD300LG levels | PROLV000333 | 10.51 | Protein levels | Vascular | 83 | 1 | 4 | 13 | |
| 178 | HRC levels | PROLV000987 | 10.42 | Protein levels | Stromal / connective | 43 | 5 | 12 | 32 | |
| 179 | RBP7 levels | PROLV001713 | 10.41 | Protein levels | Neural / glial | 36 | 3 | 9 | 11 | |
| 180 | Intestinal infection | IMMUN000066 | 10.41 | Immunologic | Vascular | 5 | 3 | 7 | 15 | |
| 181 | APP/FKBP1B ratio | PRORT000125 | 10.34 | Protein ratios | Myeloid | 0 | 4 | 15 | 21 | |
| 182 | PARK7/TNFRSF9 ratio | PRORT001621 | 10.16 | Protein ratios | Neural / glial | 8 | 3 | 6 | 18 | |
| 183 | ANGPTL3/TFPI ratio | PRORT000099 | 10.12 | Protein ratios | Hepatocyte | 73 | 2 | 11 | 18 | |
| 184 | C21orf58 levels | PROLV000231 | 10.10 | Protein levels | Hepatocyte | 0 | 4 | 10 | 17 | |
| 185 | PRTG levels | PROLV001650 | 10.10 | Protein levels | Hepatocyte | 34 | 4 | 11 | 17 | |
| 186 | Intracerebral haemorrhage | VASCU000014 | 10.09 | Vascular | Stromal / connective | 0 | 6 | 14 | 20 | |
| 187 | CCN3/PGF ratio | PRORT000374 | 9.97 | Protein ratios | Vascular | 2 | 4 | 6 | 28 | |
| 188 | Free androgen index | ENDOC000007 | 9.94 | Endocrine | Hepatocyte | 616 | 1 | 6 | 20 | |
| 189 | CD40LG/TNFSF14 ratio | PRORT000454 | 9.94 | Protein ratios | Hepatocyte | 11 | 5 | 17 | 43 | |
| 190 | CD200 levels | PROLV000316 | 9.94 | Protein levels | Adipose | 41 | 1 | 7 | 7 | |
| 191 | COLEC12/OGN ratio | PRORT000705 | 9.87 | Protein ratios | Stromal / connective | 12 | 3 | 11 | 19 | |
| 192 | Nucleoside metabolites | METAB000061 | 9.83 | Metabolites | Vascular | 0 | 0 | 1 | 2 | |
| 193 | CD69/CDKN2D ratio | PRORT000487 | 9.83 | Protein ratios | Vascular | 6 | 3 | 8 | 16 | |
| 194 | DPP6/SEZ6L ratio | PRORT000947 | 9.82 | Protein ratios | Adipose | 8 | 3 | 10 | 14 | |
| 195 | PON1 levels | PROLV001600 | 9.82 | Protein levels | Granulosa cell | 40 | 5 | 14 | 21 | |
| 196 | AGRN/HSPG2 ratio | PRORT000048 | 9.82 | Protein ratios | Stromal / connective | 22 | 7 | 7 | 25 | |
| 197 | Medication, coronary artery disease | VASCU000037 | 9.73 | Vascular | Vascular | 121 | 5 | 8 | 17 | |
| 198 | HJV levels | PROLV000971 | 9.71 | Protein levels | Hepatocyte | 12 | 4 | 12 | 35 | |
| 199 | CHRDL1/SMOC2 ratio | PRORT000614 | 9.70 | Protein ratios | Adipose | 3 | 3 | 7 | 14 | |
| 200 | FNDC1 levels | PROLV000820 | 9.63 | Protein levels | Hepatocyte | 14 | 3 | 13 | 22 | |
| 201 | BTN2A1/SMOC2 ratio | PRORT000260 | 9.61 | Protein ratios | Myeloid | 49 | 4 | 8 | 21 | |
| 202 | Body size, adult | BMORP000003 | 9.61 | Body morphology | Stromal / connective | 300 | 3 | 6 | 8 | |
| 203 | FAM3B/FGF19 ratio | PRORT001111 | 9.60 | Protein ratios | Hepatocyte | 18 | 2 | 7 | 14 | |
| 204 | VIT levels | PROLV002162 | 9.57 | Protein levels | Myeloid | 11 | 6 | 14 | 27 | |
| 205 | Fasciectomy | MSKEL000045 | 9.55 | Musculoskeletal | Stromal / connective | 11 | 3 | 8 | 14 | |
| 206 | NPY/SMOC1 ratio | PRORT001596 | 9.55 | Protein ratios | Hepatocyte | 49 | 2 | 8 | 14 | |
| 207 | CCL14 levels | PROLV000280 | 9.55 | Protein levels | Vascular | 34 | 3 | 9 | 13 | |
| 208 | FAP/LRRN1 ratio | PRORT001116 | 9.43 | Protein ratios | Muscle / cardiac | 42 | 5 | 15 | 34 | |
| 209 | PTPRZ1 levels | PROLV001682 | 9.43 | Protein levels | Myeloid | 82 | 3 | 10 | 17 | |
| 210 | CD74/LILRB4 ratio | PRORT000505 | 9.41 | Protein ratios | Vascular | 42 | 4 | 9 | 21 | |
| 211 | GFRAL levels | PROLV000879 | 9.36 | Protein levels | Vascular | 26 | 2 | 9 | 20 | |
| 212 | ANGPTL7 levels | PROLV000099 | 9.35 | Protein levels | Stromal / connective | 32 | 2 | 9 | 13 | |
| 213 | PECAM1/SOD2 ratio | PRORT001662 | 9.25 | Protein ratios | Myeloid | 17 | 5 | 13 | 18 | |
| 214 | BCL2 levels | PROLV000185 | 9.23 | Protein levels | Lymphocyte | 0 | 5 | 18 | 27 | |
| 215 | DBH levels | PROLV000596 | 9.22 | Protein levels | Myeloid | 48 | 2 | 8 | 16 | |
| 216 | CCDC80/CHRDL1 ratio | PRORT000333 | 9.22 | Protein ratios | Vascular | 10 | 1 | 5 | 15 | |
| 217 | ITGAM/ITGAV ratio | PRORT001375 | 9.20 | Protein ratios | Myeloid | 72 | 4 | 16 | 25 | |
| 218 | APOM levels | PROLV000128 | 9.20 | Protein levels | Hepatocyte | 122 | 2 | 8 | 20 | |
| 219 | TPM2 levels | PROLV002095 | 9.20 | Protein levels | Hepatocyte | 9 | 3 | 10 | 17 | |
| 220 | CD244/FCRL6 ratio | PRORT000408 | 9.16 | Protein ratios | Lymphocyte | 9 | 2 | 12 | 33 | |
| 221 | LGALS3 levels | PROLV001202 | 9.12 | Protein levels | Vascular | 28 | 1 | 2 | 8 | |
| 222 | CKAP2 levels | PROLV000438 | 9.09 | Protein levels | Neural / glial | 1 | 4 | 7 | 19 | |
| 223 | ITGAV levels | PROLV001110 | 9.08 | Protein levels | Hepatocyte | 116 | 4 | 14 | 24 | |
| 224 | DLK1/PIK3IP1 ratio | PRORT000912 | 9.04 | Protein ratios | Stromal / connective | 1 | 4 | 10 | 35 | |
| 225 | ADGRE2/CD58 ratio | PRORT000028 | 9.01 | Protein ratios | Myeloid | 43 | 3 | 11 | 17 | |
| 226 | TNN levels | PROLV002083 | 9.00 | Protein levels | Stromal / connective | 16 | 2 | 9 | 11 | |
| 227 | Trunk fat percentage | BCOMP000018 | 8.96 | Body composition | Neural / glial | 276 | 3 | 10 | 17 | |
| 228 | AHCY/HSPA1A ratio | PRORT000055 | 8.95 | Protein ratios | Lymphocyte | 10 | 3 | 12 | 39 | |
| 229 | White matter lesion volume | NIMAG000027 | 8.95 | Neuroimaging | Stromal / connective | 30 | 4 | 10 | 14 | |
| 230 | ADAMTSL2 levels | PROLV000036 | 8.91 | Protein levels | Hepatocyte | 72 | 3 | 14 | 23 | |
| 231 | Osteopenia | MSKEL000009 | 8.89 | Musculoskeletal | Adipose | 0 | 2 | 10 | 35 | |
| 232 | DKKL1 levels | PROLV000623 | 8.86 | Protein levels | Hepatocyte | 77 | 4 | 10 | 25 | |
| 233 | CD164/PARK7 ratio | PRORT000389 | 8.86 | Protein ratios | Neural / glial | 0 | 6 | 10 | 25 | |
| 234 | CD109 levels | PROLV000309 | 8.84 | Protein levels | Neural / glial | 31 | 4 | 14 | 36 | |
| 235 | Medication, angiotensin receptor blocker | VASCU000029 | 8.84 | Vascular | Adipose | 0 | 1 | 8 | 19 | |
| 236 | CCL22/TIMP3 ratio | PRORT000352 | 8.81 | Protein ratios | Vascular | 5 | 2 | 7 | 19 | |
| 237 | NCS1/NPY ratio | PRORT001576 | 8.79 | Protein ratios | Hepatocyte | 58 | 2 | 7 | 15 | |
| 238 | CX3CL1/LAYN ratio | PRORT000809 | 8.79 | Protein ratios | Vascular | 12 | 2 | 9 | 12 | |
| 239 | NOTCH3 levels | PROLV001418 | 8.77 | Protein levels | Hepatocyte | 166 | 2 | 12 | 29 | |
| 240 | SELE levels | PROLV001803 | 8.70 | Protein levels | Vascular | 55 | 2 | 4 | 14 | |
| 241 | AXL levels | PROLV000167 | 8.66 | Protein levels | Myeloid | 83 | 4 | 14 | 44 | |
| 242 | PODXL levels | PROLV001595 | 8.66 | Protein levels | Vascular | 18 | 1 | 5 | 12 | |
| 243 | CD70 levels | PROLV000353 | 8.64 | Protein levels | Muscle / cardiac | 6 | 3 | 11 | 20 | |
| 244 | PTPRN2/RTBDN ratio | PRORT001724 | 8.63 | Protein ratios | Neural / glial | 7 | 2 | 6 | 18 | |
| 245 | Mental disorder | PSYCH000013 | 8.61 | Psychiatric | Neural / glial | 21 | 2 | 9 | 20 | |
| 246 | CIAPIN1/SNX9 ratio | PRORT000617 | 8.61 | Protein ratios | Vascular | 0 | 4 | 15 | 42 | |
| 247 | EPCAM levels | PROLV000715 | 8.60 | Protein levels | Vascular | 30 | 1 | 7 | 12 | |
| 248 | Tonsillar and adenoidal disorders | RESPI000040 | 8.56 | Respiratory | Myeloid | 125 | 2 | 10 | 27 | |
| 249 | SERPINA3 levels | PROLV001817 | 8.55 | Protein levels | Myeloid | 2 | 3 | 8 | 14 | |
| 250 | IL13RA1 levels | PROLV001047 | 8.52 | Protein levels | Hepatocyte | 1 | 3 | 10 | 21 | |
| 251 | CAPG levels | PROLV000262 | 8.51 | Protein levels | Lymphocyte | 34 | 3 | 16 | 42 | |
| 252 | PDGFB/SPARC ratio | PRORT001645 | 8.50 | Protein ratios | Granulosa cell | 9 | 4 | 11 | 31 | |
| 253 | AIFM1/PLXNA4 ratio | PRORT000060 | 8.47 | Protein ratios | Hepatocyte | 9 | 2 | 10 | 26 | |
| 254 | VSNL1 levels | PROLV002173 | 8.47 | Protein levels | Myeloid | 44 | 2 | 9 | 20 | |
| 255 | Bone infection | IMMUN000053 | 8.46 | Immunologic | Myeloid | 0 | 3 | 10 | 24 | |
| 256 | CLK2 levels | PROLV000460 | 8.45 | Protein levels | Hepatocyte | 11 | 2 | 7 | 20 | |
| 257 | MATN2/SCARA5 ratio | PRORT001494 | 8.43 | Protein ratios | Stromal / connective | 12 | 5 | 9 | 19 | |
| 258 | Cardiac procedure, angioplasty | VASCU000057 | 8.41 | Vascular | Vascular | 102 | 4 | 10 | 20 | |
| 259 | Alport syndrome | NEPHR000003 | 8.38 | Nephrourologic | Lymphocyte | 3 | 3 | 4 | 20 | |
| 260 | PRELP levels | PROLV001627 | 8.35 | Protein levels | Stromal / connective | 71 | 4 | 9 | 11 | |
| 261 | Forced vital capacity, FVC | RESPI000020 | 8.33 | Respiratory | Stromal / connective | 487 | 4 | 6 | 8 | |
| 262 | Benign neoplasm, Adipose | MALIG000001 | 8.32 | Malignancy | Adipose | 1 | 2 | 6 | 14 | |
| 263 | PTX3 levels | PROLV001685 | 8.25 | Protein levels | Vascular | 51 | 3 | 11 | 17 | |
| 264 | AMIGO2 levels | PROLV000086 | 8.23 | Protein levels | Vascular | 39 | 1 | 6 | 15 | |
| 265 | MXRA8 levels | PROLV001355 | 8.23 | Protein levels | Myeloid | 78 | 5 | 12 | 24 | |
| 266 | ITGB1 levels | PROLV001111 | 8.22 | Protein levels | Myeloid | 78 | 4 | 10 | 28 | |
| 267 | HAMP levels | PROLV000950 | 8.21 | Protein levels | Vascular | 8 | 5 | 10 | 10 | |
| 268 | FGF19/SCG2 ratio | PRORT001139 | 8.20 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 13 | |
| 269 | Angina pectoris | CARDI000039 | 8.20 | Cardiac | Vascular | 317 | 5 | 9 | 18 | |
| 270 | MYOC/NOTCH3 ratio | PRORT001566 | 8.19 | Protein ratios | Hepatocyte | 9 | 1 | 8 | 24 | |
| 271 | ISLR2 levels | PROLV001101 | 8.19 | Protein levels | Granulosa cell | 65 | 4 | 11 | 16 | |
| 272 | Cardiac angiography | CARDI000047 | 8.17 | Cardiac | Stromal / connective | 14 | 3 | 8 | 17 | |
| 273 | GPA33 levels | PROLV000918 | 8.16 | Protein levels | Vascular | 66 | 2 | 10 | 11 | |
| 274 | Diverticular disease | GASTR000011 | 8.12 | Gastrointestinal | Stromal / connective | 95 | 3 | 6 | 17 | |
| 275 | Wisdom tooth surgery | DENTA000005 | 8.11 | Dental | B / plasma cell | 0 | 7 | 15 | 30 | |
| 276 | BLMH/PEAR1 ratio | PRORT000236 | 8.11 | Protein ratios | Hepatocyte | 17 | 3 | 13 | 15 | |
| 277 | Coagulation disorder | HEMAT000017 | 8.09 | Hematologic | Stromal / connective | 25 | 1 | 3 | 10 | |
| 278 | SCARF2/TNFRSF21 ratio | PRORT001763 | 8.09 | Protein ratios | Myeloid | 9 | 5 | 8 | 25 | |
| 279 | Valvular heart disease | CARDI000054 | 8.03 | Cardiac | Vascular | 15 | 5 | 9 | 24 | |
| 280 | BCAM levels | PROLV000181 | 8.02 | Protein levels | Hepatocyte | 79 | 2 | 14 | 15 | |
| 281 | C3 levels | PROLV000232 | 8.01 | Protein levels | Myeloid | 55 | 2 | 6 | 14 | |
| 282 | MAVS/PPP1R9B ratio | PRORT001498 | 8.01 | Protein ratios | Adipose | 0 | 3 | 12 | 33 | |
| 283 | Ventricular mass-to-volume ratio | CARDI000013 | 7.96 | Cardiac | Muscle / cardiac | 40 | 3 | 5 | 17 | |
| 284 | FUT8/VEGFC ratio | PRORT001193 | 7.96 | Protein ratios | Vascular | 3 | 5 | 21 | 43 | |
| 285 | Total protein levels | PROLV002131 | 7.89 | Protein levels | Myeloid | 897 | 4 | 12 | 26 | |
| 286 | NPL levels | PROLV001423 | 7.89 | Protein levels | Myeloid | 36 | 4 | 8 | 19 | |
| 287 | CLMP/TGFBR2 ratio | PRORT000670 | 7.88 | Protein ratios | Adipose | 11 | 2 | 6 | 6 | |
| 288 | ALKBH3 levels | PROLV000080 | 7.84 | Protein levels | Myeloid | 0 | 4 | 14 | 18 | |
| 289 | FABP2/RBP2 ratio | PRORT001099 | 7.78 | Protein ratios | Neural / glial | 2 | 4 | 14 | 20 | |
| 290 | FURIN/IGSF3 ratio | PRORT001183 | 7.69 | Protein ratios | Hepatocyte | 11 | 1 | 8 | 15 | |
| 291 | Coronary revascularization | VASCU000059 | 7.61 | Vascular | Vascular | 384 | 4 | 9 | 25 | |
| 292 | BCL2L15 levels | PROLV000188 | 7.59 | Protein levels | B / plasma cell | 9 | 5 | 9 | 29 | |
| 293 | FAP/THBS4 ratio | PRORT001117 | 7.55 | Protein ratios | Hepatocyte | 21 | 4 | 12 | 33 | |
| 294 | ITGBL1 levels | PROLV001117 | 7.51 | Protein levels | Vascular | 82 | 3 | 11 | 14 | |
| 295 | CX3CL1 levels | PROLV000573 | 7.48 | Protein levels | Vascular | 67 | 2 | 4 | 14 | |
| 296 | ADAMTSL4 levels | PROLV000037 | 7.43 | Protein levels | Myeloid | 49 | 3 | 12 | 24 | |
| 297 | CLMP/TNFRSF19 ratio | PRORT000671 | 7.40 | Protein ratios | Stromal / connective | 0 | 2 | 3 | 9 | |
| 298 | ADGRE2 levels | PROLV000043 | 7.39 | Protein levels | Myeloid | 136 | 3 | 10 | 22 | |
| 299 | CD300LG/CD93 ratio | PRORT000433 | 7.36 | Protein ratios | Vascular | 3 | 2 | 5 | 16 | |
| 300 | Isoleucine | METAB000024 | 7.34 | Metabolites | Hepatocyte | 28 | 3 | 6 | 20 | |
| 301 | Eye disorder | OPHTH000008 | 7.31 | Ophthalmic | Neural / glial | 4 | 1 | 1 | 7 | |
| 302 | Female genital disorder | REPRO000006 | 7.28 | Reproductive | Stromal / connective | 14 | 4 | 9 | 13 | |
| 303 | FGFR2 levels | PROLV000801 | 7.28 | Protein levels | Adipose | 45 | 0 | 5 | 11 | |
| 304 | COL6A3 levels | PROLV000492 | 7.26 | Protein levels | Stromal / connective | 38 | 2 | 4 | 12 | |
| 305 | TSPAN8 levels | PROLV002116 | 7.26 | Protein levels | Hepatocyte | 56 | 1 | 9 | 15 | |
| 306 | Joint disorder | MSKEL000015 | 7.25 | Musculoskeletal | Stromal / connective | 2 | 3 | 10 | 14 | |
| 307 | Aortic aneurysm | VASCU000002 | 7.23 | Vascular | Vascular | 163 | 5 | 11 | 20 | |
| 308 | NCR3 levels | PROLV001383 | 7.19 | Protein levels | Adipose | — | 3 | 10 | 28 | |
| 309 | CRIP2 levels | PROLV000523 | 7.15 | Protein levels | Myeloid | 32 | 5 | 13 | 19 | |
| 310 | DPP6/SEZ6L2 ratio | PRORT000948 | 7.13 | Protein ratios | Myeloid | 37 | 4 | 14 | 16 | |
| 311 | Acquired absence of organs | MISCL000027 | 7.11 | Miscellaneous | Neural / glial | 1 | 4 | 12 | 15 | |
| 312 | TINAGL1 levels | PROLV002041 | 7.11 | Protein levels | Vascular | 55 | 4 | 8 | 15 | |
| 313 | MFAP4 levels | PROLV001305 | 7.10 | Protein levels | Myeloid | 75 | 4 | 9 | 20 | |
| 314 | CCL27 levels | PROLV000294 | 7.07 | Protein levels | Myeloid | 146 | 2 | 10 | 16 | |
| 315 | Thigh muscle volume | BMORP000020 | 7.06 | Body morphology | Muscle / cardiac | 16 | 4 | 8 | 17 | |
| 316 | CR2 levels | PROLV000514 | 7.05 | Protein levels | B / plasma cell | 95 | 3 | 9 | 11 | |
| 317 | HSPG2 levels | PROLV000999 | 7.05 | Protein levels | Adipose | 16 | 2 | 5 | 13 | |
| 318 | MOG/RTBDN ratio | PRORT001552 | 7.04 | Protein ratios | Stromal / connective | 4 | 2 | 8 | 21 | |
| 319 | Fracture | MSKEL000011 | 7.03 | Musculoskeletal | Stromal / connective | 27 | 1 | 1 | 1 | |
| 320 | PTPRM levels | PROLV001678 | 7.02 | Protein levels | Vascular | 80 | 2 | 8 | 18 | |
| 321 | CREG1/NAAA ratio | PRORT000752 | 7.00 | Protein ratios | Granulosa cell | 9 | 3 | 11 | 23 | |
| 322 | DLK1 levels | PROLV000625 | 6.99 | Protein levels | Muscle / cardiac | 29 | 4 | 9 | 25 | |
| 323 | Coronary artery disease, CAD | VASCU000020 | 6.99 | Vascular | Vascular | 661 | 3 | 10 | 23 | |
| 324 | Brain neuroimaging quality metric | NIMAG000006 | 6.99 | Neuroimaging | Muscle / cardiac | 29 | 1 | 2 | 6 | |
| 325 | Sulcal opening distance | NIMAG000012 | 6.98 | Neuroimaging | Vascular | 11 | 5 | 9 | 18 | |
| 326 | LGALS8/VWF ratio | PRORT001455 | 6.98 | Protein ratios | Granulosa cell | 1 | 4 | 10 | 24 | |
| 327 | Aortic elasticity | VASCU000049 | 6.96 | Vascular | Vascular | 20 | 3 | 5 | 12 | |
| 328 | HPGDS/ITGAV ratio | PRORT001300 | 6.95 | Protein ratios | Hepatocyte | 10 | 3 | 11 | 27 | |
| 329 | CLEC14A/PIK3IP1 ratio | PRORT000627 | 6.94 | Protein ratios | Vascular | 6 | 2 | 9 | 14 | |
| 330 | GAPDH levels | PROLV000853 | 6.94 | Protein levels | Muscle / cardiac | 0 | 3 | 9 | 33 | |
| 331 | Eyelid disorder | OPHTH000019 | 6.87 | Ophthalmic | Adipose | 14 | 1 | 1 | 3 | |
| 332 | Barrett's oesophagus | GASTR000046 | 6.86 | Gastrointestinal | Stromal / connective | 11 | 2 | 6 | 14 | |
| 333 | JAM2/TGFBR2 ratio | PRORT001397 | 6.85 | Protein ratios | Adipose | 13 | 0 | 4 | 8 | |
| 334 | SNX9/STIP1 ratio | PRORT001801 | 6.84 | Protein ratios | Vascular | 0 | 6 | 15 | 31 | |
| 335 | Carpal tunnel surgery | MSKEL000044 | 6.81 | Musculoskeletal | Stromal / connective | 5 | 4 | 6 | 11 | |
| 336 | Fibromuscular dysplasia | VASCU000024 | 6.79 | Vascular | Stromal / connective | 1 | 3 | 6 | 11 | |
| 337 | Liver enzyme elevation | HPBIL000019 | 6.78 | Hepatopancreatobiliary | Myeloid | 3 | 2 | 6 | 24 | |
| 338 | NAAA levels | PROLV001369 | 6.77 | Protein levels | Hepatocyte | 124 | 1 | 5 | 11 | |
| 339 | PAMR1 levels | PROLV001493 | 6.76 | Protein levels | Myeloid | 137 | 3 | 13 | 23 | |
| 340 | TFPI2 levels | PROLV002016 | 6.76 | Protein levels | Myeloid | 105 | 2 | 7 | 15 | |
| 341 | Muscle fat infiltration | BCOMP000011 | 6.75 | Body composition | Myeloid | 40 | 2 | 8 | 20 | |
| 342 | OLR1 levels | PROLV001467 | 6.74 | Protein levels | Myeloid | 37 | 2 | 7 | 17 | |
| 343 | Operation, respiratory | RESPI000025 | 6.73 | Respiratory | Vascular | 61 | 3 | 12 | 22 | |
| 344 | LILRB4 levels | PROLV001215 | 6.73 | Protein levels | Myeloid | 162 | 2 | 8 | 19 | |
| 345 | HSPG2/VASN ratio | PRORT001310 | 6.72 | Protein ratios | Vascular | 16 | 4 | 7 | 21 | |
| 346 | HYAL1 levels | PROLV001001 | 6.70 | Protein levels | Vascular | 33 | 3 | 10 | 14 | |
| 347 | CX3CL1/RGMB ratio | PRORT000811 | 6.68 | Protein ratios | Vascular | 14 | 1 | 7 | 18 | |
| 348 | ADGRE5/GAS6 ratio | PRORT000030 | 6.68 | Protein ratios | Myeloid | 116 | 4 | 10 | 23 | |
| 349 | COL24A1 levels | PROLV000486 | 6.67 | Protein levels | Stromal / connective | 2 | 5 | 10 | 25 | |
| 350 | CDH2/CDHR2 ratio | PRORT000552 | 6.66 | Protein ratios | Hepatocyte | 39 | 1 | 6 | 11 | |
| 351 | Intracranial volume | NIMAG000025 | 6.66 | Neuroimaging | Muscle / cardiac | 0 | 3 | 8 | 18 | |
| 352 | Optic cup area | OPHTH000028 | 6.65 | Ophthalmic | Vascular | 5 | 3 | 9 | 14 | |
| 353 | LEPR levels | PROLV001200 | 6.62 | Protein levels | Myeloid | 79 | 3 | 10 | 26 | |
| 354 | DKK4/REG1A ratio | PRORT000909 | 6.62 | Protein ratios | Hepatocyte | 32 | 2 | 8 | 16 | |
| 355 | Myocardial infarction | CARDI000042 | 6.62 | Cardiac | Vascular | 343 | 3 | 9 | 12 | |
| 356 | FSTL3/SPON2 ratio | PRORT001182 | 6.60 | Protein ratios | Hepatocyte | 3 | 2 | 9 | 23 | |
| 357 | DAB2/TBL1X ratio | PRORT000841 | 6.60 | Protein ratios | Granulosa cell | 1 | 5 | 12 | 35 | |
| 358 | Physical function | MISCL000041 | 6.58 | Miscellaneous | Stromal / connective | 502 | 3 | 4 | 9 | |
| 359 | AGRN/BTN2A1 ratio | PRORT000046 | 6.58 | Protein ratios | Adipose | 70 | 2 | 7 | 7 | |
| 360 | PON3 levels | PROLV001602 | 6.50 | Protein levels | Hepatocyte | 81 | 4 | 9 | 26 | |
| 361 | PON2/PON3 ratio | PRORT001698 | 6.46 | Protein ratios | Hepatocyte | 8 | 2 | 6 | 20 | |
| 362 | Retinal vascular morphology | OPHTH000045 | 6.45 | Ophthalmic | Vascular | 253 | 2 | 5 | 7 | |
| 363 | Body fat percentage, hormone-adjusted | BCOMP000001 | 6.44 | Body composition | Hepatocyte | 237 | 2 | 6 | 9 | |
| 364 | MCAM levels | PROLV001283 | 6.43 | Protein levels | Granulosa cell | 164 | 2 | 6 | 15 | |
| 365 | DLL4 levels | PROLV000627 | 6.43 | Protein levels | Epithelial | 2 | 1 | 10 | 16 | |
| 366 | Fatty liver disease, nonalcoholic | HPBIL000031 | 6.42 | Hepatopancreatobiliary | Vascular | 19 | 1 | 7 | 16 | |
| 367 | IGF1 levels | PROLV001025 | 6.39 | Protein levels | Hepatocyte | 1,341 | 1 | 7 | 13 | |
| 368 | EGF/TNFSF14 ratio | PRORT000999 | 6.38 | Protein ratios | Hepatocyte | 12 | 4 | 17 | 36 | |
| 369 | CLEC1B/MGLL ratio | PRORT000643 | 6.38 | Protein ratios | Vascular | 24 | 6 | 14 | 30 | |
| 370 | CD99/MMP3 ratio | PRORT000535 | 6.35 | Protein ratios | Hepatocyte | 6 | 1 | 7 | 14 | |
| 371 | PSAP levels | PROLV001653 | 6.34 | Protein levels | Myeloid | 52 | 2 | 7 | 16 | |
| 372 | BMPER levels | PROLV000206 | 6.33 | Protein levels | Myeloid | 1 | 1 | 8 | 12 | |
| 373 | ROBO1/SPON1 ratio | PRORT001744 | 6.33 | Protein ratios | Vascular | 3 | 3 | 7 | 12 | |
| 374 | SLC39A5 levels | PROLV001881 | 6.30 | Protein levels | Hepatocyte | 133 | 4 | 11 | 29 | |
| 375 | FUT3 or FUT5 levels | PROLV000838 | 6.29 | Protein levels | Hepatocyte | 85 | 2 | 17 | 39 | |
| 376 | CTSF/SMPDL3A ratio | PRORT000802 | 6.27 | Protein ratios | Hepatocyte | 30 | 1 | 7 | 18 | |
| 377 | INHBC levels | PROLV001088 | 6.25 | Protein levels | Hepatocyte | 91 | 2 | 8 | 18 | |
| 378 | CCN3 levels | PROLV000303 | 6.24 | Protein levels | Vascular | 8 | 1 | 4 | 10 | |
| 379 | COMP levels | PROLV000496 | 6.21 | Protein levels | Myeloid | 133 | 3 | 11 | 17 | |
| 380 | DSCAM levels | PROLV000654 | 6.19 | Protein levels | Myeloid | 110 | 4 | 10 | 20 | |
| 381 | F3 levels | PROLV000746 | 6.15 | Protein levels | Vascular | 50 | 0 | 8 | 7 | |
| 382 | WIF1 levels | PROLV002193 | 6.13 | Protein levels | Vascular | 116 | 2 | 7 | 15 | |
| 383 | COL3A1 levels | PROLV000489 | 6.10 | Protein levels | Myeloid | 15 | 4 | 10 | 22 | |
| 384 | DNAJA2/HPCAL1 ratio | PRORT000922 | 6.09 | Protein ratios | Myeloid | 2 | 5 | 16 | 37 | |
| 385 | LAMP1 levels | PROLV001180 | 6.08 | Protein levels | Myeloid | 47 | 3 | 9 | 19 | |
| 386 | DSG4 levels | PROLV000657 | 6.07 | Protein levels | Cutaneous epithelium | 24 | 1 | 7 | 10 | |
| 387 | NCAM1 levels | PROLV001377 | 6.05 | Protein levels | Muscle / cardiac | 119 | 4 | 11 | 24 | |
| 388 | HSD11B1/SMPD1 ratio | PRORT001302 | 6.03 | Protein ratios | Hepatocyte | 78 | 1 | 6 | 17 | |
| 389 | ACVRL1/TNFRSF9 ratio | PRORT000018 | 6.02 | Protein ratios | Myeloid | 12 | 2 | 11 | 19 | |
| 390 | Low hand grip strength | MSKEL000032 | 6.02 | Musculoskeletal | Muscle / cardiac | 1 | 4 | 10 | 21 | |
| 391 | TNFRSF4/TNFRSF9 ratio | PRORT001854 | 6.02 | Protein ratios | Stromal / connective | 5 | 2 | 8 | 18 | |
| 392 | Retinal detachments and defects | OPHTH000039 | 6.01 | Ophthalmic | Stromal / connective | 2 | 3 | 7 | 22 | |
| 393 | Peripheral nerve disorder | NEURO000031 | 5.99 | Neurologic | Stromal / connective | 5 | 2 | 5 | 10 | |
| 394 | PDCD1LG2 levels | PROLV001516 | 5.98 | Protein levels | Hepatocyte | 48 | 1 | 7 | 10 | |
| 395 | Musculoskeletal soft tissue disorder | MSKEL000029 | 5.97 | Musculoskeletal | Stromal / connective | 30 | 4 | 7 | 17 | |
| 396 | RGMB/SMOC2 ratio | PRORT001737 | 5.95 | Protein ratios | Myeloid | 30 | 4 | 10 | 19 | |
| 397 | RND3 levels | PROLV001743 | 5.94 | Protein levels | Hepatocyte | 16 | 2 | 10 | 23 | |
| 398 | PTPRB levels | PROLV001673 | 5.93 | Protein levels | Vascular | 89 | 3 | 11 | 17 | |
| 399 | IFNGR2 levels | PROLV001021 | 5.93 | Protein levels | Myeloid | 122 | 5 | 14 | 30 | |
| 400 | BAX levels | PROLV000180 | 5.91 | Protein levels | Vascular | 2 | 5 | 7 | 20 | |
| 401 | Aneurysm | VASCU000001 | 5.91 | Vascular | Hepatocyte | 141 | 4 | 8 | 22 | |
| 402 | DNAJC9 levels | PROLV000636 | 5.90 | Protein levels | Muscle / cardiac | 1 | 2 | 11 | 35 | |
| 403 | FUS levels | PROLV000836 | 5.87 | Protein levels | Vascular | 2 | 5 | 11 | 21 | |
| 404 | SLC27A4/TDRKH ratio | PRORT001790 | 5.85 | Protein ratios | Stromal / connective | 0 | 1 | 4 | 11 | |
| 405 | FST levels | PROLV000829 | 5.85 | Protein levels | Granulosa cell | 34 | 2 | 6 | 15 | |
| 406 | Blood pressure, BP, diastolic x sex interaction | VASCU000008 | 5.84 | Vascular | Muscle / cardiac | 0 | 2 | 12 | 23 | |
| 407 | Kidney failure, acute | NEPHR000012 | 5.83 | Nephrourologic | Lymphocyte | 0 | 2 | 15 | 24 | |
| 408 | LTBR levels | PROLV001244 | 5.81 | Protein levels | Hepatocyte | 115 | 1 | 6 | 17 | |
| 409 | DLK1/RGMB ratio | PRORT000913 | 5.81 | Protein ratios | Hepatocyte | 11 | 4 | 9 | 23 | |
| 410 | ACVRL1/TNFRSF10B ratio | PRORT000016 | 5.79 | Protein ratios | Myeloid | 40 | 3 | 11 | 16 | |
| 411 | FURIN/PLA2G15 ratio | PRORT001185 | 5.79 | Protein ratios | Adipose | 9 | 2 | 8 | 18 | |
| 412 | FHIT/PARK7 ratio | PRORT001146 | 5.78 | Protein ratios | Myeloid | 3 | 4 | 12 | 20 | |
| 413 | SCG3 levels | PROLV001785 | 5.78 | Protein levels | Vascular | 110 | 0 | 8 | 11 | |
| 414 | F7/VASN ratio | PRORT001089 | 5.78 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 12 | |
| 415 | CTSZ/NAAA ratio | PRORT000805 | 5.78 | Protein ratios | Stromal / connective | 45 | 2 | 10 | 14 | |
| 416 | TCTN3 levels | PROLV002005 | 5.77 | Protein levels | Hepatocyte | 89 | 3 | 10 | 20 | |
| 417 | Knee morphology | MSKEL000024 | 5.76 | Musculoskeletal | Stromal / connective | 0 | 4 | 7 | 17 | |
| 418 | PAPL levels | PROLV001494 | 5.72 | Protein levels | Melanocyte | 0 | 3 | 11 | 12 | |
| 419 | DKK3 levels | PROLV000621 | 5.72 | Protein levels | Myeloid | 56 | 3 | 10 | 17 | |
| 420 | Phenylalanine | METAB000027 | 5.70 | Metabolites | Hepatocyte | 104 | 1 | 4 | 10 | |
| 421 | Rotator cuff injury | MSKEL000067 | 5.68 | Musculoskeletal | Stromal / connective | 0 | 3 | 7 | 17 | |
| 422 | CDH5/PCDH17 ratio | PRORT000559 | 5.68 | Protein ratios | Vascular | 23 | 2 | 8 | 6 | |
| 423 | Spinal stenosis | MSKEL000078 | 5.67 | Musculoskeletal | Stromal / connective | 43 | 4 | 9 | 11 | |
| 424 | ADAM9 levels | PROLV000030 | 5.66 | Protein levels | Myeloid | 119 | 3 | 12 | 18 | |
| 425 | ERN1 levels | PROLV000730 | 5.65 | Protein levels | Hepatocyte | 95 | 3 | 8 | 18 | |
| 426 | AHCY/FABP5 ratio | PRORT000054 | 5.64 | Protein ratios | Muscle / cardiac | 0 | 1 | 8 | 14 | |
| 427 | CDH5/NOTCH1 ratio | PRORT000558 | 5.64 | Protein ratios | Vascular | 22 | 2 | 9 | 12 | |
| 428 | SMPD1 levels | PROLV001901 | 5.63 | Protein levels | Hepatocyte | 179 | 1 | 7 | 16 | |
| 429 | Anal and rectal disorder | GASTR000001 | 5.62 | Gastrointestinal | Gastrointestinal epithelium | 1 | 0 | 7 | 4 | |
| 430 | CHL1 levels | PROLV000430 | 5.59 | Protein levels | Hepatocyte | 10 | 3 | 6 | 15 | |
| 431 | PI16 levels | PROLV001553 | 5.57 | Protein levels | Myeloid | 144 | 1 | 6 | 16 | |
| 432 | CRIM1 levels | PROLV000522 | 5.56 | Protein levels | Vascular | 58 | 2 | 9 | 16 | |
| 433 | MANSC1/PODXL ratio | PRORT001483 | 5.56 | Protein ratios | Hepatocyte | 5 | 1 | 8 | 13 | |
| 434 | CSF unidentified metabolite | METAB000075 | 5.54 | Metabolites | Muscle / cardiac | 1 | 0 | 2 | 3 | |
| 435 | GFRA3 levels | PROLV000878 | 5.53 | Protein levels | Myeloid | 91 | 1 | 8 | 21 | |
| 436 | FST/FSTL3 ratio | PRORT001180 | 5.53 | Protein ratios | Stromal / connective | 0 | 4 | 15 | 20 | |
| 437 | Hypoxaemia | RESPI000029 | 5.53 | Respiratory | Vascular | 15 | 2 | 13 | 27 | |
| 438 | ITGA11 levels | PROLV001104 | 5.52 | Protein levels | Hepatocyte | 66 | 3 | 11 | 20 | |
| 439 | Ischaemic heart disease | CARDI000041 | 5.52 | Cardiac | Vascular | 595 | 3 | 10 | 19 | |
| 440 | RAP1A levels | PROLV001704 | 5.52 | Protein levels | Lymphocyte | 15 | 2 | 12 | 20 | |
| 441 | CX3CL1/DSG2 ratio | PRORT000807 | 5.50 | Protein ratios | Vascular | 33 | 1 | 6 | 8 | |
| 442 | TNR levels | PROLV002084 | 5.49 | Protein levels | Vascular | 90 | 3 | 8 | 15 | |
| 443 | ACY1/GSTA1 ratio | PRORT000020 | 5.48 | Protein ratios | Hepatocyte | 61 | 3 | 12 | 27 | |
| 444 | CDHR2 levels | PROLV000379 | 5.45 | Protein levels | Hepatocyte | 103 | 2 | 13 | 22 | |
| 445 | HMCN2 levels | PROLV000977 | 5.44 | Protein levels | Stromal / connective | 14 | 5 | 10 | 18 | |
| 446 | Pustular skin disorder | DERMA000018 | 5.41 | Dermatologic | Hepatocyte | 0 | 1 | 5 | 13 | |
| 447 | NEO1 levels | PROLV001392 | 5.40 | Protein levels | Muscle / cardiac | 0 | 3 | 11 | 19 | |
| 448 | GMPR2 levels | PROLV000903 | 5.39 | Protein levels | Lymphocyte | 3 | 3 | 11 | 40 | |
| 449 | SMOC1 levels | PROLV001899 | 5.38 | Protein levels | Hepatocyte | 129 | 1 | 6 | 15 | |
| 450 | FLRT2 levels | PROLV000814 | 5.37 | Protein levels | Hepatocyte | 50 | 1 | 6 | 14 | |
| 451 | SNAP29/SNX9 ratio | PRORT001797 | 5.36 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 28 | |
| 452 | ANGPT2 levels | PROLV000094 | 5.35 | Protein levels | Hepatocyte | 72 | 3 | 10 | 21 | |
| 453 | ERBB2 levels | PROLV000724 | 5.32 | Protein levels | Hepatocyte | 97 | 1 | 8 | 17 | |
| 454 | MESD/NCK2 ratio | PRORT001516 | 5.31 | Protein ratios | Neural / glial | 8 | 4 | 10 | 17 | |
| 455 | LAMA4/NID1 ratio | PRORT001419 | 5.30 | Protein ratios | Vascular | 14 | 5 | 12 | 24 | |
| 456 | CD55/CHI3L1 ratio | PRORT000469 | 5.29 | Protein ratios | Hepatocyte | 11 | 2 | 9 | 24 | |
| 457 | PTP4A3 levels | PROLV001670 | 5.28 | Protein levels | Myeloid | 2 | 2 | 16 | 21 | |
| 458 | OMD levels | PROLV001468 | 5.27 | Protein levels | Myeloid | 95 | 4 | 7 | 13 | |
| 459 | THBS2 levels | PROLV002026 | 5.25 | Protein levels | Lymphocyte | 30 | 2 | 11 | 39 | |
| 460 | EGF/MGLL ratio | PRORT000996 | 5.25 | Protein ratios | Vascular | 11 | 3 | 8 | 27 | |
| 461 | TP53I3 levels | PROLV002091 | 5.22 | Protein levels | Lymphocyte | 4 | 3 | 12 | 38 | |
| 462 | Brain neuroimaging feature | NIMAG000005 | 5.22 | Neuroimaging | Stromal / connective | 137 | 0 | 2 | 9 | |
| 463 | Fatty acids, undecenoic acid | LIPID000030 | 5.20 | Lipids | Stromal / connective | 0 | 3 | 8 | 17 | |
| 464 | FOLH1 levels | PROLV000821 | 5.20 | Protein levels | Hepatocyte | 7 | 0 | 3 | 10 | |
| 465 | BSG/LAMP3 ratio | PRORT000248 | 5.18 | Protein ratios | Myeloid | 33 | 1 | 8 | 14 | |
| 466 | DDR1 levels | PROLV000610 | 5.17 | Protein levels | Melanocyte | 92 | 3 | 14 | 23 | |
| 467 | IL1R2 levels | PROLV001061 | 5.17 | Protein levels | Hepatocyte | 116 | 3 | 9 | 15 | |
| 468 | AKR7L levels | PROLV000073 | 5.14 | Protein levels | Hepatocyte | 29 | 3 | 9 | 22 | |
| 469 | APOA4 levels | PROLV000119 | 5.12 | Protein levels | Granulosa cell | 12 | 0 | 5 | 7 | |
| 470 | CST3/IGFBP6 ratio | PRORT000783 | 5.10 | Protein ratios | Stromal / connective | 7 | 3 | 15 | 19 | |
| 471 | CA11 levels | PROLV000240 | 5.06 | Protein levels | Adipose | 0 | 3 | 6 | 23 | |
| 472 | Steatohepatitis, nonalcoholic | HPBIL000032 | 5.05 | Hepatopancreatobiliary | Renal epithelium | 0 | 0 | 5 | 7 | |
| 473 | ESAM/LAMA4 ratio | PRORT001063 | 5.02 | Protein ratios | Vascular | 16 | 4 | 9 | 15 | |
| 474 | Tuberculosis, TB | IMMUN000050 | 5.02 | Immunologic | Muscle / cardiac | — | 3 | 8 | 12 | |
| 475 | DDHD2 levels | PROLV000609 | 5.01 | Protein levels | Vascular | 9 | 4 | 10 | 15 | |
| 476 | DNAJB1/STIP1 ratio | PRORT000930 | 5.01 | Protein ratios | Hepatocyte | 29 | 2 | 8 | 12 | |
| 477 | FKBP5/TBCC ratio | PRORT001159 | 5.01 | Protein ratios | Hepatocyte | 10 | 1 | 8 | 14 | |
| 478 | CHCHD6 levels | PROLV000425 | 5.01 | Protein levels | Stromal / connective | 0 | 3 | 8 | 26 | |
| 479 | IRAK1/NFATC1 ratio | PRORT001368 | 5.00 | Protein ratios | Hepatocyte | 1 | 3 | 8 | 22 | |
| 480 | RAD23B levels | PROLV001703 | 5.00 | Protein levels | Stromal / connective | 1 | 4 | 9 | 14 | |
| 481 | Visual impairment | OPHTH000046 | 4.99 | Ophthalmic | Stromal / connective | 28 | 0 | 2 | 7 | |
| 482 | ARF6 levels | PROLV000133 | 4.98 | Protein levels | Stromal / connective | 50 | 5 | 15 | 21 | |
| 483 | LIFR levels | PROLV001210 | 4.97 | Protein levels | Vascular | 75 | 4 | 12 | 46 | |
| 484 | AARSD1/UBAC1 ratio | PRORT000002 | 4.97 | Protein ratios | Muscle / cardiac | 0 | 3 | 6 | 13 | |
| 485 | Knee extension strength | MSKEL000031 | 4.97 | Musculoskeletal | Stromal / connective | 0 | 2 | 6 | 10 | |
| 486 | CLEC14A/EPHB4 ratio | PRORT000626 | 4.97 | Protein ratios | Vascular | 10 | 3 | 7 | 17 | |
| 487 | IDS/SMPDL3A ratio | PRORT001330 | 4.97 | Protein ratios | Hepatocyte | 53 | 2 | 8 | 19 | |
| 488 | BCAM/CDH5 ratio | PRORT000206 | 4.95 | Protein ratios | Vascular | 42 | 1 | 12 | 12 | |
| 489 | Menopausal disorder | REPRO000020 | 4.94 | Reproductive | Hepatocyte | 0 | 5 | 9 | 25 | |
| 490 | Optic disc morphology | OPHTH000030 | 4.94 | Ophthalmic | Vascular | 8 | 1 | 10 | 15 | |
| 491 | ALCAM/ENPP2 ratio | PRORT000070 | 4.92 | Protein ratios | Hepatocyte | 51 | 3 | 12 | 18 | |
| 492 | RBP5 levels | PROLV001712 | 4.91 | Protein levels | Adipose | 3 | 0 | 8 | 32 | |
| 493 | GPHA2 levels | PROLV000922 | 4.91 | Protein levels | Stromal / connective | 9 | 0 | 2 | 3 | |
| 494 | FABP5 levels | PROLV000755 | 4.90 | Protein levels | Stromal / connective | 7 | 5 | 11 | 35 | |
| 495 | Hearing loss, conductive | AUDIO000007 | 4.88 | Auditory | Stromal / connective | 3 | 1 | 7 | 10 | |
| 496 | BIRC2/CD40LG ratio | PRORT000235 | 4.88 | Protein ratios | Hepatocyte | 0 | 3 | 10 | 29 | |
| 497 | ESAM levels | PROLV000733 | 4.87 | Protein levels | Muscle / cardiac | 25 | 3 | 8 | 11 | |
| 498 | CES1 levels | PROLV000405 | 4.87 | Protein levels | Hepatocyte | 148 | 1 | 8 | 13 | |
| 499 | ATRN levels | PROLV000163 | 4.85 | Protein levels | Vascular | 52 | 6 | 17 | 29 | |
| 500 | CLUL1 levels | PROLV000468 | 4.85 | Protein levels | Hepatocyte | 71 | 4 | 9 | 27 | |
| 501 | PDGFC/TFPI ratio | PRORT001653 | 4.85 | Protein ratios | Hepatocyte | 52 | 2 | 12 | 21 | |
| 502 | ANKRD54 levels | PROLV000101 | 4.84 | Protein levels | Vascular | 2 | 2 | 4 | 18 | |
| 503 | Breast disorder | BREAS000002 | 4.84 | Breast | Respiratory epithelium | 0 | 0 | 11 | 13 | |
| 504 | SLC9A3R2 levels | PROLV001886 | 4.82 | Protein levels | Vascular | 16 | 2 | 7 | 14 | |
| 505 | Macular puckering of retina | OPHTH000037 | 4.81 | Ophthalmic | Stromal / connective | 17 | 3 | 8 | 11 | |
| 506 | INHBB levels | PROLV001087 | 4.81 | Protein levels | Hepatocyte | 38 | 6 | 10 | 14 | |
| 507 | GALNT10/IGSF3 ratio | PRORT001201 | 4.81 | Protein ratios | Hepatocyte | 8 | 3 | 11 | 21 | |
| 508 | CD59/SCARB2 ratio | PRORT000483 | 4.80 | Protein ratios | Myeloid | 16 | 4 | 10 | 20 | |
| 509 | CNTN5 levels | PROLV000479 | 4.79 | Protein levels | Myeloid | 1 | 4 | 6 | 13 | |
| 510 | Testosterone | ENDOC000010 | 4.79 | Endocrine | Hepatocyte | 939 | 2 | 6 | 23 | |
| 511 | FGF19 levels | PROLV000793 | 4.79 | Protein levels | Hepatocyte | 49 | 1 | 7 | 22 | |
| 512 | ACVRL1/EFNA4 ratio | PRORT000014 | 4.78 | Protein ratios | Vascular | 35 | 4 | 10 | 14 | |
| 513 | Family history, coronary artery disease | VASCU000021 | 4.78 | Vascular | Vascular | 26 | 0 | 2 | 7 | |
| 514 | Sputum production | RESPI000033 | 4.77 | Respiratory | Myeloid | 0 | 4 | 9 | 14 | |
| 515 | Ganglion cyst | MSKEL000065 | 4.77 | Musculoskeletal | Stromal / connective | 0 | 1 | 3 | 12 | |
| 516 | Gestational age at birth | REPRO000040 | 4.77 | Reproductive | Neural / glial | 0 | 1 | 7 | 10 | |
| 517 | TSTA3 levels | PROLV002118 | 4.76 | Protein levels | Vascular | 10 | 3 | 7 | 12 | |
| 518 | CXCL16/NOTCH1 ratio | PRORT000822 | 4.76 | Protein ratios | Vascular | 15 | 3 | 15 | 44 | |
| 519 | EFNA1/PIK3IP1 ratio | PRORT000989 | 4.76 | Protein ratios | Hepatocyte | 29 | 2 | 10 | 21 | |
| 520 | Trunk mass | BCOMP000019 | 4.76 | Body composition | Stromal / connective | 381 | 4 | 10 | 14 | |
| 521 | FHIT/PMVK ratio | PRORT001147 | 4.76 | Protein ratios | Myeloid | 0 | 2 | 8 | 24 | |
| 522 | LRP11/NECTIN2 ratio | PRORT001460 | 4.75 | Protein ratios | Vascular | 14 | 2 | 10 | 10 | |
| 523 | Gut microbial abundance, CAG-177 | GASTR000020 | 4.74 | Gastrointestinal | Salivary epithelium | 0 | 0 | 7 | 5 | |
| 524 | SPON1 levels | PROLV001936 | 4.74 | Protein levels | Vascular | 33 | 0 | 2 | 7 | |
| 525 | CCL15/CCL23 ratio | PRORT000341 | 4.73 | Protein ratios | Myeloid | 7 | 1 | 6 | 27 | |
| 526 | LAG3/VCAM1 ratio | PRORT001418 | 4.73 | Protein ratios | Hepatocyte | 24 | 4 | 13 | 36 | |
| 527 | PDGFA/SPARC ratio | PRORT001637 | 4.72 | Protein ratios | Hematopoietic progenitor | 6 | 3 | 6 | 15 | |
| 528 | Arterial dissection | VASCU000003 | 4.72 | Vascular | Stromal / connective | 16 | 0 | 2 | 15 | |
| 529 | SPARCL1 levels | PROLV001924 | 4.71 | Protein levels | Hepatocyte | 112 | 2 | 9 | 18 | |
| 530 | ACYP1 levels | PROLV000021 | 4.70 | Protein levels | Lymphocyte | 14 | 2 | 12 | 34 | |
| 531 | CRTAC1 levels | PROLV000529 | 4.69 | Protein levels | Myeloid | 136 | 2 | 12 | 16 | |
| 532 | EFEMP1/FSTL3 ratio | PRORT000986 | 4.68 | Protein ratios | Stromal / connective | 14 | 4 | 6 | 20 | |
| 533 | Bone marrow fat fraction, spine | MSKEL000002 | 4.68 | Musculoskeletal | Vascular | 67 | 2 | 8 | 16 | |
| 534 | APOD levels | PROLV000123 | 4.68 | Protein levels | Myeloid | 62 | 2 | 10 | 15 | |
| 535 | APRT/NSFL1C ratio | PRORT000136 | 4.67 | Protein ratios | Lymphocyte | 0 | 2 | 9 | 25 | |
| 536 | ALB levels | PROLV000077 | 4.66 | Protein levels | Myeloid | 1,602 | 3 | 15 | 21 | |
| 537 | NAAA/SMPD1 ratio | PRORT001569 | 4.65 | Protein ratios | Granulosa cell | 6 | 3 | 12 | 20 | |
| 538 | CTSL levels | PROLV000566 | 4.65 | Protein levels | Myeloid | 163 | 2 | 9 | 15 | |
| 539 | Forced expiratory volume, FEV | RESPI000019 | 4.64 | Respiratory | Stromal / connective | 370 | 1 | 5 | 13 | |
| 540 | Trigger finger | MSKEL000072 | 4.64 | Musculoskeletal | Stromal / connective | 7 | 2 | 4 | 8 | |
| 541 | BCL2L2 levels | PROLV000189 | 4.64 | Protein levels | Vascular | 0 | 2 | 5 | 9 | |
| 542 | DIABLO/PRKAR1A ratio | PRORT000893 | 4.64 | Protein ratios | Myeloid | 12 | 3 | 12 | 18 | |
| 543 | ACVRL1/SCARB2 ratio | PRORT000015 | 4.63 | Protein ratios | Myeloid | 46 | 2 | 9 | 18 | |
| 544 | CELA3A/CTRB1 ratio | PRORT000595 | 4.62 | Protein ratios | Vascular | 12 | 2 | 6 | 9 | |
| 545 | ADAMTS8/FAP ratio | PRORT000026 | 4.59 | Protein ratios | Muscle / cardiac | 0 | 2 | 4 | 7 | |
| 546 | Benign neoplasm, Endocrine | MALIG000003 | 4.58 | Malignancy | Myeloid | 1 | 3 | 9 | 18 | |
| 547 | DSC2/SPINT1 ratio | PRORT000951 | 4.55 | Protein ratios | Epithelial | 23 | 0 | 7 | 3 | |
| 548 | Stimulant use disorder | PSYCH000048 | 4.55 | Psychiatric | Neural / glial | 0 | 4 | 10 | 24 | |
| 549 | NSFL1C/PSMG3 ratio | PRORT001599 | 4.54 | Protein ratios | Neural / glial | 19 | 4 | 7 | 20 | |
| 550 | LAMA4 levels | PROLV001178 | 4.51 | Protein levels | Vascular | 67 | 2 | 8 | 19 | |
| 551 | CA5A/KRT18 ratio | PRORT000288 | 4.50 | Protein ratios | Hepatocyte | 18 | 1 | 10 | 19 | |
| 552 | PFDN5 levels | PROLV001539 | 4.49 | Protein levels | Muscle / cardiac | 0 | 4 | 9 | 24 | |
| 553 | AXL/MSR1 ratio | PRORT000182 | 4.49 | Protein ratios | Myeloid | 28 | 4 | 16 | 18 | |
| 554 | BPIFB2 levels | PROLV000211 | 4.49 | Protein levels | Hepatocyte | 112 | 1 | 6 | 17 | |
| 555 | GLB1/IMPA1 ratio | PRORT001216 | 4.48 | Protein ratios | Myeloid | 65 | 4 | 11 | 19 | |
| 556 | ITGA2 levels | PROLV001105 | 4.48 | Protein levels | Vascular | 76 | 3 | 13 | 27 | |
| 557 | Retinal vascular disorder | OPHTH000044 | 4.48 | Ophthalmic | Vascular | 0 | 1 | 6 | 13 | |
| 558 | CASP8/DDX58 ratio | PRORT000321 | 4.48 | Protein ratios | Myeloid | 2 | 2 | 8 | 11 | |
| 559 | MEGF9 levels | PROLV001294 | 4.47 | Protein levels | Hepatocyte | 93 | 2 | 11 | 23 | |
| 560 | HNRNPUL1 levels | PROLV000983 | 4.46 | Protein levels | Lymphocyte | 15 | 4 | 11 | 41 | |
| 561 | EFEMP1/IL18BP ratio | PRORT000987 | 4.45 | Protein ratios | Stromal / connective | 1 | 1 | 6 | 16 | |
| 562 | CD22/CD79B ratio | PRORT000399 | 4.45 | Protein ratios | B / plasma cell | 16 | 1 | 7 | 10 | |
| 563 | Hypertension, secondary | VASCU000026 | 4.45 | Vascular | Renal epithelium | — | 0 | 17 | 26 | |
| 564 | SESTD1 levels | PROLV001838 | 4.45 | Protein levels | Muscle / cardiac | 12 | 4 | 8 | 23 | |
| 565 | CREG1/SMPDL3A ratio | PRORT000753 | 4.44 | Protein ratios | Hepatocyte | 10 | 2 | 10 | 28 | |
| 566 | TNFRSF4/TNFRSF8 ratio | PRORT001853 | 4.44 | Protein ratios | Vascular | 2 | 2 | 6 | 10 | |
| 567 | GFRA1/SPON2 ratio | PRORT001208 | 4.43 | Protein ratios | Hepatocyte | 3 | 1 | 6 | 11 | |
| 568 | ANPEP levels | PROLV000103 | 4.43 | Protein levels | Hepatocyte | 62 | 1 | 8 | 18 | |
| 569 | GFRA1 levels | PROLV000876 | 4.41 | Protein levels | Myeloid | 22 | 2 | 8 | 15 | |
| 570 | ERBB2/FURIN ratio | PRORT001042 | 4.40 | Protein ratios | Hepatocyte | 39 | 2 | 7 | 17 | |
| 571 | Varicose veins, VV | VASCU000061 | 4.39 | Vascular | Vascular | 132 | 1 | 4 | 11 | |
| 572 | MASP1 levels | PROLV001276 | 4.39 | Protein levels | Hepatocyte | 99 | 1 | 7 | 7 | |
| 573 | PPP2R2A levels | PROLV001618 | 4.38 | Protein levels | Lymphocyte | 0 | 3 | 9 | 29 | |
| 574 | CA6 levels | PROLV000247 | 4.38 | Protein levels | Myeloid | 51 | 2 | 14 | 21 | |
| 575 | Circulatory disorder | VASCU000025 | 4.37 | Vascular | Neural / glial | 1 | 1 | 5 | 14 | |
| 576 | DNAJA2/FIS1 ratio | PRORT000920 | 4.36 | Protein ratios | Granulosa cell | 0 | 4 | 13 | 24 | |
| 577 | FCRL2/LY9 ratio | PRORT001130 | 4.35 | Protein ratios | B / plasma cell | 27 | 2 | 8 | 38 | |
| 578 | SCARA5/SCARF2 ratio | PRORT001758 | 4.34 | Protein ratios | Vascular | 4 | 1 | 3 | 18 | |
| 579 | PTPRS levels | PROLV001681 | 4.33 | Protein levels | Lymphocyte | 21 | 2 | 9 | 37 | |
| 580 | AHNAK2 levels | PROLV000063 | 4.33 | Protein levels | Adipose | 19 | 0 | 2 | 13 | |
| 581 | HLA-E levels | PROLV000976 | 4.31 | Protein levels | Stromal / connective | 104 | 1 | 7 | 30 | |
| 582 | Liver enzyme levels, AST | HPBIL000014 | 4.30 | Hepatopancreatobiliary | Hepatocyte | 1,947 | 3 | 13 | 18 | |
| 583 | Testicular disorder | REPRO000015 | 4.27 | Reproductive | Adipose | 8 | 1 | 8 | 13 | |
| 584 | NTRK2 levels | PROLV001447 | 4.26 | Protein levels | Myeloid | 73 | 3 | 11 | 21 | |
| 585 | APOA2 levels | PROLV000118 | 4.26 | Protein levels | Hepatocyte | 134 | 3 | 9 | 20 | |
| 586 | MSTN levels | PROLV001345 | 4.25 | Protein levels | Muscle / cardiac | 17 | 2 | 9 | 17 | |
| 587 | IGFBP3 levels | PROLV001030 | 4.25 | Protein levels | Hepatocyte | 67 | 2 | 10 | 17 | |
| 588 | JAM2 levels | PROLV001124 | 4.24 | Protein levels | Vascular | 4 | 0 | 5 | 7 | |
| 589 | CDH5/TEK ratio | PRORT000561 | 4.24 | Protein ratios | Vascular | 42 | 2 | 8 | 11 | |
| 590 | Paradoxical eczema | IMMUN000036 | 4.24 | Immunologic | Myeloid | 0 | 1 | 6 | 16 | |
| 591 | PSMG3 levels | PROLV001660 | 4.23 | Protein levels | Muscle / cardiac | 21 | 3 | 10 | 24 | |
| 592 | Depression or anxiety | PSYCH000025 | 4.23 | Psychiatric | Neural / glial | 52 | 4 | 9 | 10 | |
| 593 | PCDH1 levels | PROLV001504 | 4.23 | Protein levels | Hepatocyte | 21 | 3 | 8 | 14 | |
| 594 | Labour complication | REPRO000037 | 4.22 | Reproductive | Stromal / connective | 0 | 1 | 4 | 7 | |
| 595 | TXN levels | PROLV002123 | 4.22 | Protein levels | Lymphocyte | 1 | 3 | 11 | 28 | |
| 596 | Hydrocephalus | NEURO000002 | 4.22 | Neurologic | Stromal / connective | 10 | 2 | 4 | 16 | |
| 597 | JAM2/RGMB ratio | PRORT001396 | 4.21 | Protein ratios | Vascular | 2 | 2 | 6 | 11 | |
| 598 | CD59/CST6 ratio | PRORT000481 | 4.21 | Protein ratios | Respiratory epithelium | 3 | 0 | 12 | 7 | |
| 599 | NXPH3 levels | PROLV001458 | 4.20 | Protein levels | Stromal / connective | 3 | 1 | 4 | 15 | |
| 600 | DNER levels | PROLV000637 | 4.19 | Protein levels | Vascular | 69 | 1 | 6 | 18 | |
| 601 | IL6ST/MARCO ratio | PRORT001355 | 4.19 | Protein ratios | Myeloid | 22 | 3 | 8 | 14 | |
| 602 | Triglycerides/phosphoglycerides | LIPID000042 | 4.18 | Lipids | Hepatocyte | 839 | 3 | 8 | 17 | |
| 603 | FYN levels | PROLV000843 | 4.17 | Protein levels | Muscle / cardiac | 0 | 3 | 12 | 32 | |
| 604 | GGCT levels | PROLV000881 | 4.17 | Protein levels | Lymphocyte | 3 | 4 | 9 | 32 | |
| 605 | FCRL2/SEMA7A ratio | PRORT001131 | 4.16 | Protein ratios | B / plasma cell | 15 | 1 | 8 | 26 | |
| 606 | PROC levels | PROLV001637 | 4.16 | Protein levels | Hepatocyte | 164 | 2 | 6 | 14 | |
| 607 | ALCAM/CDH5 ratio | PRORT000068 | 4.16 | Protein ratios | Hepatocyte | 26 | 1 | 8 | 15 | |
| 608 | CIAPIN1/SPARC ratio | PRORT000618 | 4.15 | Protein ratios | Myeloid | 9 | 1 | 8 | 13 | |
| 609 | CD27/FCRL5 ratio | PRORT000413 | 4.14 | Protein ratios | Neural / glial | 71 | 6 | 14 | 27 | |
| 610 | Lactose intolerance | METBL000003 | 4.14 | Metabolic | Renal epithelium | 0 | 0 | 7 | 4 | |
| 611 | Keloid and scarring | DERMA000041 | 4.14 | Dermatologic | Muscle / cardiac | 17 | 2 | 3 | 19 | |
| 612 | Venous disease | VASCU000064 | 4.13 | Vascular | Vascular | 101 | 2 | 6 | 15 | |
| 613 | Liver fat | HPBIL000023 | 4.13 | Hepatopancreatobiliary | Neural / glial | 33 | 2 | 5 | 16 | |
| 614 | Family history, chronic lung disease | RESPI000002 | 4.12 | Respiratory | Stromal / connective | 0 | 2 | 6 | 14 | |
| 615 | IFNAR1 levels | PROLV001018 | 4.12 | Protein levels | Myeloid | 52 | 4 | 11 | 23 | |
| 616 | LTBP2/MYOC ratio | PRORT001464 | 4.12 | Protein ratios | Neural / glial | 0 | 3 | 8 | 16 | |
| 617 | SRC/TBL1X ratio | PRORT001814 | 4.10 | Protein ratios | Platelet | 1 | 4 | 11 | 15 | |
| 618 | Retinal thickness | OPHTH000043 | 4.10 | Ophthalmic | Neural / glial | 58 | 1 | 5 | 7 | |
| 619 | CCN3/COL6A3 ratio | PRORT000372 | 4.10 | Protein ratios | Stromal / connective | 26 | 0 | 3 | 5 | |
| 620 | Fatty acids metabolites | METAB000052 | 4.10 | Metabolites | Hepatocyte | 20 | 2 | 4 | 18 | |
| 621 | Ocular refraction | OPHTH000033 | 4.10 | Ophthalmic | Stromal / connective | 39 | 6 | 10 | 25 | |
| 622 | MYOC levels | PROLV001363 | 4.09 | Protein levels | Vascular | 33 | 0 | 5 | 12 | |
| 623 | UBXN1 levels | PROLV002134 | 4.09 | Protein levels | Lymphocyte | 5 | 4 | 15 | 38 | |
| 624 | DIABLO/VSIR ratio | PRORT000894 | 4.08 | Protein ratios | Myeloid | 18 | 3 | 15 | 17 | |
| 625 | Triglycerides/HDL cholesterol | LIPID000041 | 4.07 | Lipids | Hepatocyte | 792 | 3 | 9 | 19 | |
| 626 | RBKS levels | PROLV001709 | 4.06 | Protein levels | Hepatocyte | 23 | 1 | 7 | 17 | |
| 627 | SFRP1 levels | PROLV001844 | 4.06 | Protein levels | Vascular | 20 | 3 | 6 | 17 | |
| 628 | LY6D/PLA2G10 ratio | PRORT001469 | 4.04 | Protein ratios | Vascular | 48 | 3 | 10 | 17 | |
| 629 | Weight, birth | BMORP000018 | 4.03 | Body morphology | Vascular | 117 | 2 | 6 | 16 | |
| 630 | FCER2/TNFRSF9 ratio | PRORT001122 | 4.03 | Protein ratios | B / plasma cell | 32 | 2 | 11 | 39 | |
| 631 | PRR4 levels | PROLV001642 | 4.02 | Protein levels | Epithelial | 44 | 0 | 8 | 9 | |
| 632 | CD276 levels | PROLV000326 | 4.02 | Protein levels | Adipose | 14 | 0 | 4 | 4 | |
| 633 | ADGRE5/NOTCH1 ratio | PRORT000032 | 4.02 | Protein ratios | Myeloid | 54 | 3 | 13 | 15 | |
| 634 | APEX1/LSP1 ratio | PRORT000116 | 4.01 | Protein ratios | Myeloid | 14 | 4 | 9 | 14 | |
| 635 | Acne | DERMA000028 | 3.99 | Dermatologic | Cutaneous epithelium | 14 | 0 | 8 | 7 | |
| 636 | SCLY/SORD ratio | PRORT001764 | 3.99 | Protein ratios | Myeloid | 1 | 3 | 10 | 16 | |
| 637 | Eustachian tube disorder | AUDIO000015 | 3.96 | Auditory | Epithelial | 0 | 0 | 6 | 8 | |
| 638 | C2/LILRB4 ratio | PRORT000264 | 3.96 | Protein ratios | Myeloid | 71 | 3 | 11 | 24 | |
| 639 | CD40LG/SERPINE1 ratio | PRORT000453 | 3.95 | Protein ratios | Hematopoietic progenitor | 2 | 2 | 9 | 18 | |
| 640 | NHLRC3 levels | PROLV001403 | 3.95 | Protein levels | Stromal / connective | 23 | 5 | 9 | 27 | |
| 641 | CTSC/PLA2G15 ratio | PRORT000798 | 3.95 | Protein ratios | Hepatocyte | 20 | 1 | 10 | 34 | |
| 642 | REG1A/REG4 ratio | PRORT001730 | 3.94 | Protein ratios | Hepatocyte | 35 | 1 | 6 | 14 | |
| 643 | ASPN levels | PROLV000153 | 3.94 | Protein levels | Stromal / connective | 10 | 4 | 12 | 35 | |
| 644 | Gynaecomastia | BREAS000003 | 3.93 | Breast | Granulosa cell | 0 | 1 | 4 | 11 | |
| 645 | TLR4 levels | PROLV002044 | 3.93 | Protein levels | Lymphocyte | 0 | 1 | 6 | 23 | |
| 646 | PPT1 levels | PROLV001621 | 3.92 | Protein levels | Melanocyte | 2 | 3 | 7 | 26 | |
| 647 | RBP2 levels | PROLV001711 | 3.92 | Protein levels | Neural / glial | 30 | 1 | 10 | 15 | |
| 648 | Fall risk | MSKEL000043 | 3.91 | Musculoskeletal | Stromal / connective | 1 | 0 | 5 | 10 | |
| 649 | TNFRSF11B levels | PROLV002061 | 3.90 | Protein levels | Hepatocyte | 94 | 1 | 6 | 16 | |
| 650 | Liver enzyme levels, ALP | HPBIL000012 | 3.90 | Hepatopancreatobiliary | Hepatocyte | 1,521 | 1 | 5 | 16 | |
| 651 | Cardiac implants and grafts | CARDI000048 | 3.90 | Cardiac | Vascular | 36 | 4 | 9 | 23 | |
| 652 | GP2/LGALS8 ratio | PRORT001230 | 3.90 | Protein ratios | Epithelial | 14 | 1 | 4 | 11 | |
| 653 | PLA2G15/PRCP ratio | PRORT001670 | 3.89 | Protein ratios | Myeloid | 44 | 3 | 11 | 21 | |
| 654 | Fasciitis | MSKEL000063 | 3.88 | Musculoskeletal | Stromal / connective | 16 | 1 | 3 | 8 | |
| 655 | MED18/SMAD1 ratio | PRORT001509 | 3.88 | Protein ratios | Hepatocyte | 2 | 4 | 15 | 37 | |
| 656 | Bone marrow fat fraction, femur | MSKEL000001 | 3.87 | Musculoskeletal | Adipose | 27 | 3 | 8 | 14 | |
| 657 | NPY levels | PROLV001429 | 3.87 | Protein levels | Hepatocyte | 131 | 2 | 6 | 21 | |
| 658 | Cardiac pacemaker | CARDI000049 | 3.87 | Cardiac | Muscle / cardiac | 22 | 3 | 14 | 22 | |
| 659 | ABHD14B/CCS ratio | PRORT000004 | 3.86 | Protein ratios | Myeloid | 4 | 5 | 12 | 18 | |
| 660 | Physical decline | AGING000005 | 3.86 | Aging | Muscle / cardiac | 0 | 4 | 15 | 14 | |
| 661 | Cutaneous and subcutaneous lipoma | DERMA000001 | 3.85 | Dermatologic | Lymphocyte | 0 | 3 | 13 | 26 | |
| 662 | ITPR1 levels | PROLV001122 | 3.85 | Protein levels | Vascular | 20 | 3 | 13 | 25 | |
| 663 | TDRKH levels | PROLV002008 | 3.85 | Protein levels | Vascular | 14 | 4 | 6 | 16 | |
| 664 | COL18A1 levels | PROLV000484 | 3.83 | Protein levels | Stromal / connective | 55 | 3 | 7 | 12 | |
| 665 | FURIN/INHBC ratio | PRORT001184 | 3.83 | Protein ratios | Hepatocyte | 45 | 1 | 8 | 23 | |
| 666 | Childhood maltreatment | PSYCH000052 | 3.83 | Psychiatric | Vascular | 0 | 1 | 4 | 7 | |
| 667 | MET/PTPRF ratio | PRORT001520 | 3.81 | Protein ratios | Hepatocyte | 19 | 1 | 9 | 9 | |
| 668 | CD55/ITGB1 ratio | PRORT000470 | 3.81 | Protein ratios | Vascular | 51 | 2 | 8 | 22 | |
| 669 | Hydrocele | REPRO000012 | 3.80 | Reproductive | Stromal / connective | 7 | 0 | 8 | 15 | |
| 670 | Cerebrovascular disease | VASCU000013 | 3.80 | Vascular | Vascular | 56 | 2 | 6 | 9 | |
| 671 | Synovium, tendon and bursa disorder | MSKEL000057 | 3.79 | Musculoskeletal | Stromal / connective | 1 | 2 | 4 | 7 | |
| 672 | Valine | METAB000032 | 3.79 | Metabolites | Hepatocyte | 209 | 2 | 6 | 18 | |
| 673 | Ocular motility and refraction disorder | OPHTH000024 | 3.78 | Ophthalmic | Adipose | 7 | 3 | 5 | 12 | |
| 674 | DYNLL1 levels | PROLV000666 | 3.78 | Protein levels | B / plasma cell | 0 | 1 | 4 | 4 | |
| 675 | Kidney transplant | NEPHR000023 | 3.78 | Nephrourologic | Muscle / cardiac | 0 | 1 | 12 | 19 | |
| 676 | CELA3A/CPB1 ratio | PRORT000594 | 3.78 | Protein ratios | Vascular | 26 | 1 | 3 | 10 | |
| 677 | FAM3B levels | PROLV000766 | 3.77 | Protein levels | Gastrointestinal epithelium | 66 | 0 | 6 | 7 | |
| 678 | ADGRE2/IFNGR1 ratio | PRORT000029 | 3.77 | Protein ratios | Myeloid | 51 | 2 | 10 | 15 | |
| 679 | SMAD5 levels | PROLV001897 | 3.77 | Protein levels | Myeloid | 95 | 2 | 6 | 11 | |
| 680 | Biventricular shape | CARDI000010 | 3.77 | Cardiac | Muscle / cardiac | 44 | 2 | 4 | 12 | |
| 681 | MCAM/NCAM1 ratio | PRORT001505 | 3.75 | Protein ratios | Adipose | 14 | 4 | 6 | 17 | |
| 682 | ANGPTL2 levels | PROLV000096 | 3.74 | Protein levels | Stromal / connective | 48 | 3 | 17 | 12 | |
| 683 | IL17D levels | PROLV001052 | 3.73 | Protein levels | Hepatocyte | 18 | 4 | 8 | 25 | |
| 684 | SRC/STAT5B ratio | PRORT001813 | 3.73 | Protein ratios | Hepatocyte | 0 | 3 | 12 | 22 | |
| 685 | MB levels | PROLV001281 | 3.72 | Protein levels | Muscle / cardiac | 26 | 3 | 4 | 11 | |
| 686 | LGALS8/SOD2 ratio | PRORT001453 | 3.72 | Protein ratios | Myeloid | 6 | 6 | 16 | 28 | |
| 687 | C2/SSC5D ratio | PRORT000265 | 3.72 | Protein ratios | Vascular | 15 | 1 | 6 | 10 | |
| 688 | CRH levels | PROLV000520 | 3.72 | Protein levels | Hematopoietic progenitor | 35 | 1 | 1 | 7 | |
| 689 | PMVK levels | PROLV001590 | 3.71 | Protein levels | Myeloid | 34 | 3 | 8 | 12 | |
| 690 | Chronic viral hepatitis | IMMUN000056 | 3.70 | Immunologic | Stromal / connective | 4 | 0 | 1 | 7 | |
| 691 | FN1 levels | PROLV000819 | 3.70 | Protein levels | Myeloid | 76 | 5 | 15 | 27 | |
| 692 | GRAP2/SNX9 ratio | PRORT001245 | 3.69 | Protein ratios | Hepatocyte | 6 | 4 | 7 | 27 | |
| 693 | CFHR4 levels | PROLV000416 | 3.68 | Protein levels | Hepatocyte | 61 | 2 | 9 | 16 | |
| 694 | PLA2G10 levels | PROLV001565 | 3.68 | Protein levels | Hepatocyte | 100 | 2 | 9 | 13 | |
| 695 | FABP2 levels | PROLV000752 | 3.66 | Protein levels | Myeloid | 44 | 4 | 10 | 17 | |
| 696 | C1QTNF5 levels | PROLV000225 | 3.66 | Protein levels | Myeloid | 120 | 2 | 5 | 10 | |
| 697 | Sepsis | IMMUN000071 | 3.66 | Immunologic | Vascular | — | 1 | 6 | 7 | |
| 698 | SGSH levels | PROLV001850 | 3.66 | Protein levels | Myeloid | 70 | 3 | 11 | 22 | |
| 699 | Short-chain fatty acids | METAB000053 | 3.66 | Metabolites | Granulosa cell | 20 | 5 | 12 | 17 | |
| 700 | IL1B levels | PROLV001059 | 3.64 | Protein levels | Myeloid | 2 | 3 | 11 | 18 | |
| 701 | APOA1 levels | PROLV000117 | 3.63 | Protein levels | Hepatocyte | 792 | 3 | 9 | 16 | |
| 702 | MCEE levels | PROLV001284 | 3.62 | Protein levels | Myeloid | 2 | 3 | 11 | 27 | |
| 703 | MAPK9 levels | PROLV001271 | 3.61 | Protein levels | Vascular | 0 | 3 | 8 | 17 | |
| 704 | CERT/MAX ratio | PRORT000605 | 3.61 | Protein ratios | Stromal / connective | 0 | 4 | 12 | 23 | |
| 705 | DPP4 levels | PROLV000646 | 3.61 | Protein levels | Myeloid | 44 | 3 | 12 | 22 | |
| 706 | GC levels | PROLV000864 | 3.60 | Protein levels | Myeloid | 15 | 2 | 7 | 19 | |
| 707 | IL6ST/LEPR ratio | PRORT001353 | 3.59 | Protein ratios | Hepatocyte | 42 | 3 | 10 | 13 | |
| 708 | APOA levels | PROLV000116 | 3.59 | Protein levels | Hepatocyte | 1,456 | 3 | 9 | 17 | |
| 709 | DKK4/REG1B ratio | PRORT000910 | 3.57 | Protein ratios | Hepatocyte | 27 | 1 | 10 | 15 | |
| 710 | CNTN2 levels | PROLV000476 | 3.56 | Protein levels | Vascular | 46 | 4 | 13 | 25 | |
| 711 | IGFBP4/OGN ratio | PRORT001335 | 3.56 | Protein ratios | Stromal / connective | 0 | 2 | 11 | 29 | |
| 712 | SKAP2/VSIR ratio | PRORT001788 | 3.56 | Protein ratios | Myeloid | 7 | 4 | 17 | 18 | |
| 713 | Corneal disorder | OPHTH000003 | 3.55 | Ophthalmic | Stromal / connective | 11 | 1 | 1 | 14 | |
| 714 | CRTAM/TNFRSF9 ratio | PRORT000774 | 3.55 | Protein ratios | Lymphocyte | 7 | 3 | 17 | 30 | |
| 715 | FSTL1 levels | PROLV000830 | 3.53 | Protein levels | Myeloid | 71 | 2 | 8 | 15 | |
| 716 | Endometriosis | REPRO000005 | 3.53 | Reproductive | Stromal / connective | 49 | 1 | 4 | 8 | |
| 717 | LTBR/TNFRSF14 ratio | PRORT001467 | 3.53 | Protein ratios | Stromal / connective | 0 | 4 | 11 | 23 | |
| 718 | CA1/TGM2 ratio | PRORT000270 | 3.51 | Protein ratios | Hematopoietic progenitor | 1 | 6 | 9 | 12 | |
| 719 | PAMR1/RARRES2 ratio | PRORT001620 | 3.50 | Protein ratios | Hepatocyte | 48 | 2 | 7 | 14 | |
| 720 | LY75 levels | PROLV001248 | 3.49 | Protein levels | Myeloid | 56 | 2 | 6 | 16 | |
| 721 | CLEC10A levels | PROLV000444 | 3.48 | Protein levels | Myeloid | 116 | 2 | 8 | 14 | |
| 722 | Spondylolisthesis or spondylolysis | MSKEL000079 | 3.48 | Musculoskeletal | Stromal / connective | 0 | 3 | 5 | 13 | |
| 723 | MIA levels | PROLV001311 | 3.48 | Protein levels | Neural / glial | 91 | 4 | 7 | 14 | |
| 724 | Osteomyelitis | IMMUN000068 | 3.47 | Immunologic | Stromal / connective | 19 | 2 | 4 | 5 | |
| 725 | AGER levels | PROLV000054 | 3.46 | Protein levels | Vascular | 97 | 1 | 7 | 11 | |
| 726 | NOS3 levels | PROLV001415 | 3.45 | Protein levels | Myeloid | 58 | 5 | 9 | 18 | |
| 727 | CD55 levels | PROLV000345 | 3.44 | Protein levels | Adipose | 54 | 0 | 9 | 16 | |
| 728 | SFRP4 levels | PROLV001846 | 3.44 | Protein levels | Stromal / connective | 10 | 3 | 7 | 9 | |
| 729 | DKK4 levels | PROLV000622 | 3.44 | Protein levels | Vascular | 53 | 2 | 10 | 18 | |
| 730 | TIE1 levels | PROLV002033 | 3.44 | Protein levels | Granulosa cell | 77 | 3 | 9 | 20 | |
| 731 | BLVRB/CA2 ratio | PRORT000239 | 3.44 | Protein ratios | Vascular | 0 | 0 | 7 | 11 | |
| 732 | LY6D/NECTIN4 ratio | PRORT001468 | 3.43 | Protein ratios | Cutaneous epithelium | 13 | 0 | 8 | 11 | |
| 733 | ANGPTL1 levels | PROLV000095 | 3.43 | Protein levels | Hepatocyte | 101 | 1 | 5 | 8 | |
| 734 | ENG/NOTCH1 ratio | PRORT001018 | 3.43 | Protein ratios | Vascular | 3 | 2 | 7 | 16 | |
| 735 | DSC2/EFEMP1 ratio | PRORT000950 | 3.42 | Protein ratios | Hepatocyte | 14 | 2 | 6 | 19 | |
| 736 | HPCAL1/MPIG6B ratio | PRORT001296 | 3.42 | Protein ratios | Myeloid | 11 | 2 | 6 | 9 | |
| 737 | DCTN6 levels | PROLV000604 | 3.41 | Protein levels | Vascular | 0 | 4 | 13 | 31 | |
| 738 | Atherosclerosis | VASCU000006 | 3.41 | Vascular | Hepatocyte | 177 | 2 | 10 | 20 | |
| 739 | Peripheral artery disease | VASCU000042 | 3.41 | Vascular | Vascular | 44 | 3 | 9 | 23 | |
| 740 | PLAT levels | PROLV001571 | 3.40 | Protein levels | Hepatocyte | 64 | 2 | 8 | 18 | |
| 741 | PLA2G4A/PPP1R12A ratio | PRORT001673 | 3.40 | Protein ratios | Hepatocyte | 3 | 4 | 10 | 25 | |
| 742 | Precerebral arterial stenosis and occlusion | VASCU000016 | 3.40 | Vascular | Stromal / connective | 91 | 2 | 11 | 22 | |
| 743 | ATXN2L levels | PROLV000165 | 3.40 | Protein levels | Stromal / connective | 0 | 1 | 6 | 16 | |
| 744 | Radiotherapy | MALIG000049 | 3.39 | Malignancy | Muscle / cardiac | 0 | 3 | 10 | 19 | |
| 745 | TMSB10/ZBTB16 ratio | PRORT001842 | 3.39 | Protein ratios | Muscle / cardiac | 29 | 4 | 8 | 25 | |
| 746 | S100A12 levels | PROLV001767 | 3.39 | Protein levels | Lymphocyte | 6 | 3 | 14 | 39 | |
| 747 | BCHE levels | PROLV000184 | 3.38 | Protein levels | Hepatocyte | 114 | 1 | 5 | 11 | |
| 748 | SLC51B levels | PROLV001883 | 3.37 | Protein levels | B / plasma cell | 4 | 0 | 6 | 9 | |
| 749 | F9 levels | PROLV000750 | 3.37 | Protein levels | Myeloid | 24 | 6 | 12 | 31 | |
| 750 | XRCC4 levels | PROLV002200 | 3.36 | Protein levels | Myeloid | 0 | 4 | 9 | 17 | |
| 751 | Blood pressure, BP, systolic | VASCU000011 | 3.35 | Vascular | Vascular | 1,562 | 4 | 7 | 13 | |
| 752 | CCL8 levels | PROLV000300 | 3.35 | Protein levels | Myeloid | 76 | 2 | 6 | 14 | |
| 753 | AAMDC levels | PROLV000004 | 3.35 | Protein levels | Myeloid | 19 | 1 | 5 | 7 | |
| 754 | TNFSF14 levels | PROLV002080 | 3.34 | Protein levels | Myeloid | 15 | 2 | 6 | 24 | |
| 755 | Glutamate metabolites | METAB000005 | 3.34 | Metabolites | Vascular | 0 | 0 | 2 | 5 | |
| 756 | Cataract | OPHTH000012 | 3.33 | Ophthalmic | Vascular | 103 | 0 | 4 | 9 | |
| 757 | Medication, antiplatelet | VASCU000032 | 3.33 | Vascular | Vascular | 78 | 1 | 5 | 9 | |
| 758 | SERPINB8 levels | PROLV001826 | 3.33 | Protein levels | Myeloid | 18 | 5 | 6 | 17 | |
| 759 | EFEMP1 levels | PROLV000679 | 3.32 | Protein levels | Hepatocyte | 115 | 1 | 5 | 11 | |
| 760 | IGBP1 levels | PROLV001023 | 3.31 | Protein levels | Lymphocyte | 1 | 3 | 12 | 33 | |
| 761 | External ear disorder | AUDIO000001 | 3.30 | Auditory | Hepatocyte | 0 | 2 | 8 | 19 | |
| 762 | Digital deformity | MSKEL000053 | 3.30 | Musculoskeletal | Stromal / connective | 0 | 5 | 8 | 33 | |
| 763 | IGSF3 levels | PROLV001038 | 3.29 | Protein levels | Hepatocyte | 95 | 2 | 8 | 28 | |
| 764 | CDKN1A/TBL1X ratio | PRORT000573 | 3.29 | Protein ratios | Hepatocyte | 13 | 3 | 13 | 13 | |
| 765 | CTSF/NAAA ratio | PRORT000801 | 3.28 | Protein ratios | Hepatocyte | 46 | 3 | 13 | 23 | |
| 766 | CCN1/DNAJB1 ratio | PRORT000361 | 3.28 | Protein ratios | Hepatocyte | 26 | 4 | 14 | 37 | |
| 767 | Ventricular wall thickness | CARDI000016 | 3.28 | Cardiac | Muscle / cardiac | 47 | 2 | 3 | 11 | |
| 768 | Intrahepatic cholestasis of pregnancy, ICP | HPBIL000001 | 3.27 | Hepatopancreatobiliary | Hepatocyte | 97 | 1 | 6 | 8 | |
| 769 | CFB levels | PROLV000410 | 3.27 | Protein levels | Hepatocyte | 101 | 4 | 14 | 24 | |
| 770 | SPTLC1 levels | PROLV001941 | 3.27 | Protein levels | Myeloid | 0 | 1 | 7 | 15 | |
| 771 | SORD levels | PROLV001920 | 3.27 | Protein levels | Hepatocyte | 44 | 1 | 4 | 11 | |
| 772 | CD46/TNFRSF14 ratio | PRORT000462 | 3.26 | Protein ratios | Vascular | 21 | 1 | 4 | 10 | |
| 773 | COL15A1 levels | PROLV000483 | 3.26 | Protein levels | Stromal / connective | 4 | 0 | 6 | 11 | |
| 774 | CLEC3B levels | PROLV000449 | 3.26 | Protein levels | Vascular | 23 | 3 | 7 | 16 | |
| 775 | Polycythaemia | HEMAT000012 | 3.25 | Hematologic | Vascular | 2 | 2 | 7 | 14 | |
| 776 | Chondrocalcinosis | MSKEL000014 | 3.25 | Musculoskeletal | Vascular | 0 | 1 | 6 | 12 | |
| 777 | Branched-chain amino acids | METAB000019 | 3.23 | Metabolites | Hepatocyte | 32 | 3 | 9 | 16 | |
| 778 | IL1RL1 levels | PROLV001063 | 3.23 | Protein levels | Stromal / connective | 20 | 1 | 3 | 11 | |
| 779 | COL6A3/SPON2 ratio | PRORT000701 | 3.23 | Protein ratios | Neural / glial | 20 | 3 | 6 | 25 | |
| 780 | FAM3B/GPA33 ratio | PRORT001113 | 3.23 | Protein ratios | Vascular | 17 | 0 | 4 | 7 | |
| 781 | IFIH1 levels | PROLV001015 | 3.22 | Protein levels | Vascular | 0 | 2 | 7 | 7 | |
| 782 | FGL1 levels | PROLV000803 | 3.21 | Protein levels | Hepatocyte | 58 | 3 | 12 | 23 | |
| 783 | APOE levels | PROLV000124 | 3.19 | Protein levels | Neural / glial | 46 | 4 | 13 | 21 | |
| 784 | FEV1/FVC ratio | RESPI000021 | 3.19 | Respiratory | Stromal / connective | 549 | 3 | 4 | 17 | |
| 785 | Urinary tract infection | IMMUN000074 | 3.18 | Immunologic | Neural / glial | 1 | 1 | 3 | 7 | |
| 786 | Benign neoplasm, Colorectal | MALIG000002 | 3.17 | Malignancy | Stromal / connective | 41 | 0 | 4 | 4 | |
| 787 | DPT levels | PROLV000649 | 3.17 | Protein levels | Myeloid | 31 | 4 | 11 | 21 | |
| 788 | AGT levels | PROLV000059 | 3.17 | Protein levels | Hepatocyte | 53 | 2 | 5 | 10 | |
| 789 | CXCL17/SFTPA2 ratio | PRORT000824 | 3.16 | Protein ratios | Myeloid | 3 | 2 | 8 | 18 | |
| 790 | CLSTN2/MATN2 ratio | PRORT000676 | 3.16 | Protein ratios | Hepatocyte | 25 | 2 | 8 | 16 | |
| 791 | MCAM/NTRK3 ratio | PRORT001506 | 3.16 | Protein ratios | Vascular | 17 | 2 | 8 | 14 | |
| 792 | TMPRSS11D levels | PROLV002048 | 3.15 | Protein levels | Vascular | 3 | 2 | 5 | 12 | |
| 793 | ADGRE5 levels | PROLV000044 | 3.15 | Protein levels | Myeloid | 168 | 3 | 7 | 14 | |
| 794 | Dorsopathy | MSKEL000075 | 3.15 | Musculoskeletal | Stromal / connective | 14 | 2 | 7 | 22 | |
| 795 | SNX2 levels | PROLV001913 | 3.15 | Protein levels | B / plasma cell | 8 | 1 | 6 | 17 | |
| 796 | Cancer, Cervix | MALIG000012 | 3.15 | Malignancy | Lymphocyte | 23 | 0 | 4 | 30 | |
| 797 | CD93 levels | PROLV000362 | 3.15 | Protein levels | Granulosa cell | 47 | 1 | 5 | 10 | |
| 798 | MMP3 levels | PROLV001325 | 3.13 | Protein levels | Myeloid | 51 | 1 | 6 | 8 | |
| 799 | BPIFB1 levels | PROLV000210 | 3.12 | Protein levels | Myeloid | 54 | 2 | 11 | 20 | |
| 800 | AZU1/MPO ratio | PRORT000185 | 3.12 | Protein ratios | Myeloid | 8 | 1 | 4 | 8 | |
| 801 | TALDO1 levels | PROLV001991 | 3.09 | Protein levels | Lymphocyte | 8 | 3 | 10 | 40 | |
| 802 | PVR levels | PROLV001687 | 3.09 | Protein levels | Hepatocyte | 54 | 1 | 9 | 10 | |
| 803 | GGT5 levels | PROLV000884 | 3.09 | Protein levels | Hepatocyte | 21 | 1 | 8 | 12 | |
| 804 | CDH5/PEAR1 ratio | PRORT000560 | 3.08 | Protein ratios | Hepatocyte | 6 | 1 | 8 | 30 | |
| 805 | NAGPA levels | PROLV001373 | 3.08 | Protein levels | Hepatocyte | 66 | 1 | 4 | 14 | |
| 806 | AOC3/ITGB1 ratio | PRORT000113 | 3.08 | Protein ratios | Stromal / connective | 16 | 3 | 14 | 10 | |
| 807 | RNF146 levels | PROLV001744 | 3.07 | Protein levels | Muscle / cardiac | 0 | 1 | 3 | 18 | |
| 808 | CD79B/FCRL1 ratio | PRORT000510 | 3.07 | Protein ratios | B / plasma cell | 29 | 3 | 11 | 23 | |
| 809 | HMOX2/TDRKH ratio | PRORT001291 | 3.07 | Protein ratios | Stromal / connective | 0 | 3 | 7 | 16 | |
| 810 | PCDHB15 levels | PROLV001509 | 3.05 | Protein levels | Vascular | 46 | 2 | 6 | 9 | |
| 811 | Uterine or vaginal bleeding | REPRO000044 | 3.05 | Reproductive | Stromal / connective | 0 | 5 | 8 | 16 | |
| 812 | Leucine | METAB000025 | 3.05 | Metabolites | Hepatocyte | 24 | 3 | 8 | 21 | |
| 813 | NTPROBNP levels | PROLV001446 | 3.05 | Protein levels | Muscle / cardiac | 50 | 2 | 7 | 18 | |
| 814 | ANPEP/DPP4 ratio | PRORT000101 | 3.05 | Protein ratios | Hepatocyte | 25 | 3 | 11 | 18 | |
| 815 | DCTN1/FXN ratio | PRORT000872 | 3.05 | Protein ratios | Hepatocyte | 0 | 4 | 15 | 34 | |
| 816 | ANGPTL4 levels | PROLV000098 | 3.04 | Protein levels | Hepatocyte | 49 | 3 | 9 | 23 | |
| 817 | Retinal disorder | OPHTH000040 | 3.04 | Ophthalmic | Hepatocyte | 88 | 0 | 2 | 3 | |
| 818 | TTR levels | PROLV002120 | 3.04 | Protein levels | Hepatocyte | 83 | 2 | 9 | 13 | |
| 819 | CD48 levels | PROLV000343 | 3.03 | Protein levels | B / plasma cell | 92 | 2 | 8 | 19 | |
| 820 | CNDP1 levels | PROLV000471 | 3.02 | Protein levels | Hepatocyte | 75 | 2 | 12 | 12 | |
| 821 | Taurine metabolites | METAB000014 | 3.02 | Metabolites | Vascular | 8 | 0 | 1 | 1 | |
| 822 | F7 levels | PROLV000748 | 3.02 | Protein levels | Hepatocyte | 89 | 1 | 8 | 15 | |
| 823 | MSR1 levels | PROLV001342 | 3.02 | Protein levels | Myeloid | 116 | 3 | 10 | 13 | |
| 824 | Lactate | METAB000066 | 3.01 | Metabolites | Myeloid | 0 | 1 | 5 | 10 | |
| 825 | DNAJB1/METAP2 ratio | PRORT000927 | 3.01 | Protein ratios | Hepatocyte | 23 | 3 | 10 | 18 | |
| 826 | CGREF1/FAM3C ratio | PRORT000609 | 3.00 | Protein ratios | Hepatocyte | 2 | 0 | 4 | 8 | |
| 827 | Female genital tract polyp | REPRO000009 | 3.00 | Reproductive | Stromal / connective | 2 | 3 | 18 | 49 | |
| 828 | Family medical history, none | MISCL000010 | 3.00 | Miscellaneous | Vascular | 6 | 0 | 0 | 3 | |
| 829 | Respiratory insufficiency | RESPI000031 | 3.00 | Respiratory | Hepatocyte | 0 | 4 | 10 | 29 | |
| 830 | IGFBP6/PTGDS ratio | PRORT001337 | 3.00 | Protein ratios | Myeloid | 19 | 2 | 7 | 18 | |
| 831 | IL6ST/PDGFRA ratio | PRORT001356 | 3.00 | Protein ratios | Myeloid | 19 | 2 | 7 | 24 | |
| 832 | EFNA1 levels | PROLV000681 | 2.99 | Protein levels | Vascular | 45 | 2 | 11 | 22 | |
| 833 | HEPH levels | PROLV000963 | 2.98 | Protein levels | Lymphocyte | 12 | 0 | 9 | 27 | |
| 834 | Otitis externa | AUDIO000003 | 2.98 | Auditory | Muscle / cardiac | 0 | 3 | 6 | 17 | |
| 835 | PNLIPRP2 levels | PROLV001593 | 2.98 | Protein levels | Granulosa cell | 13 | 1 | 5 | 13 | |
| 836 | OLR1/PLAUR ratio | PRORT001613 | 2.98 | Protein ratios | Myeloid | 36 | 3 | 7 | 11 | |
| 837 | MIF/SUSD2 ratio | PRORT001535 | 2.97 | Protein ratios | Vascular | 33 | 1 | 7 | 22 | |
| 838 | PDLIM7/SRC ratio | PRORT001655 | 2.97 | Protein ratios | Myeloid | 12 | 3 | 7 | 20 | |
| 839 | COL1A1 levels | PROLV000485 | 2.95 | Protein levels | B / plasma cell | 22 | 0 | 1 | 0 | |
| 840 | Tyrosine metabolites | METAB000016 | 2.95 | Metabolites | Muscle / cardiac | 0 | 2 | 4 | 16 | |
| 841 | Arm mass | BCOMP000014 | 2.95 | Body composition | Stromal / connective | 302 | 4 | 9 | 13 | |
| 842 | CLMP/GFRA1 ratio | PRORT000668 | 2.94 | Protein ratios | Hepatocyte | 49 | 2 | 9 | 18 | |
| 843 | CXCL12 levels | PROLV000578 | 2.93 | Protein levels | Lymphocyte | 15 | 2 | 7 | 18 | |
| 844 | CD300E/CXCL10 ratio | PRORT000430 | 2.93 | Protein ratios | Myeloid | 7 | 4 | 15 | 26 | |
| 845 | DNAJB1 levels | PROLV000630 | 2.93 | Protein levels | Vascular | 17 | 3 | 7 | 28 | |
| 846 | CDH17 levels | PROLV000373 | 2.93 | Protein levels | Myeloid | 57 | 1 | 5 | 14 | |
| 847 | ADGRE5/VCAM1 ratio | PRORT000034 | 2.92 | Protein ratios | Myeloid | 37 | 4 | 11 | 18 | |
| 848 | CLMP levels | PROLV000461 | 2.92 | Protein levels | Adipose | 9 | 2 | 6 | 5 | |
| 849 | LGALS9/SIGLEC1 ratio | PRORT001456 | 2.92 | Protein ratios | Myeloid | 15 | 3 | 13 | 17 | |
| 850 | CALCA levels | PROLV000255 | 2.90 | Protein levels | Stromal / connective | 6 | 4 | 7 | 22 | |
| 851 | AGR3 levels | PROLV000056 | 2.90 | Protein levels | Myeloid | 11 | 1 | 7 | 10 | |
| 852 | CD69/TXNDC5 ratio | PRORT000501 | 2.88 | Protein ratios | Vascular | 1 | 2 | 10 | 13 | |
| 853 | Cancer, Testis | MALIG000031 | 2.87 | Malignancy | B / plasma cell | 0 | 0 | 1 | 7 | |
| 854 | CPM levels | PROLV000507 | 2.86 | Protein levels | Myeloid | 138 | 3 | 11 | 11 | |
| 855 | Cancer, Lung | MALIG000019 | 2.84 | Malignancy | Lymphocyte | 41 | 0 | 1 | 3 | |
| 856 | Operation, urological | NEPHR000016 | 2.83 | Nephrourologic | Vascular | 16 | 0 | 6 | 18 | |
| 857 | RWDD1/SUMF2 ratio | PRORT001752 | 2.83 | Protein ratios | Hepatocyte | 39 | 2 | 5 | 10 | |
| 858 | Cancer, Endometrium | MALIG000014 | 2.83 | Malignancy | Lymphocyte | 8 | 2 | 14 | 50 | |
| 859 | VEGFD levels | PROLV002160 | 2.82 | Protein levels | Hepatocyte | 25 | 2 | 9 | 23 | |
| 860 | PLG levels | PROLV001577 | 2.82 | Protein levels | Granulosa cell | 46 | 5 | 14 | 28 | |
| 861 | Operation, gastrointestinal | GASTR000039 | 2.82 | Gastrointestinal | Hepatocyte | 208 | 1 | 2 | 11 | |
| 862 | CNTN4 levels | PROLV000478 | 2.82 | Protein levels | Myeloid | 28 | 0 | 1 | 5 | |
| 863 | F11R/PARK7 ratio | PRORT001072 | 2.82 | Protein ratios | Hepatocyte | 0 | 1 | 7 | 26 | |
| 864 | CNP levels | PROLV000472 | 2.82 | Protein levels | Stromal / connective | 1 | 3 | 9 | 29 | |
| 865 | Tryptophan metabolites | METAB000015 | 2.82 | Metabolites | Hepatocyte | 39 | 0 | 2 | 11 | |
| 866 | Sugar alcohols | METAB000037 | 2.81 | Metabolites | Vascular | 0 | 1 | 4 | 12 | |
| 867 | Emphysema | RESPI000011 | 2.81 | Respiratory | Hepatocyte | 1 | 1 | 7 | 16 | |
| 868 | ASGR1/GGT5 ratio | PRORT000148 | 2.81 | Protein ratios | Hepatocyte | 60 | 1 | 9 | 18 | |
| 869 | EGLN1/LSP1 ratio | PRORT001003 | 2.80 | Protein ratios | Myeloid | 12 | 2 | 9 | 15 | |
| 870 | CASP8/RILP ratio | PRORT000324 | 2.80 | Protein ratios | Hepatocyte | 2 | 3 | 8 | 19 | |
| 871 | ITGA5/VCAM1 ratio | PRORT001373 | 2.80 | Protein ratios | Myeloid | 15 | 4 | 10 | 19 | |
| 872 | GFRA3/LAYN ratio | PRORT001211 | 2.79 | Protein ratios | Adipose | 4 | 3 | 4 | 12 | |
| 873 | C5 levels | PROLV000235 | 2.79 | Protein levels | Hepatocyte | 10 | 4 | 15 | 40 | |
| 874 | AXIN1/MAVS ratio | PRORT000175 | 2.79 | Protein ratios | Neural / glial | 6 | 3 | 16 | 35 | |
| 875 | NFATC1/TJAP1 ratio | PRORT001587 | 2.79 | Protein ratios | Muscle / cardiac | 0 | 1 | 6 | 8 | |
| 876 | ALCAM/MSR1 ratio | PRORT000074 | 2.78 | Protein ratios | Myeloid | 30 | 2 | 10 | 13 | |
| 877 | PLA2G2A levels | PROLV001568 | 2.78 | Protein levels | Myeloid | 20 | 3 | 9 | 17 | |
| 878 | Lipoprotein particles | LIPID000047 | 2.78 | Lipids | Hepatocyte | 781 | 3 | 9 | 18 | |
| 879 | CCL11/CCL2 ratio | PRORT000335 | 2.77 | Protein ratios | Muscle / cardiac | 13 | 2 | 5 | 11 | |
| 880 | FCN2 levels | PROLV000782 | 2.76 | Protein levels | Myeloid | 70 | 3 | 9 | 14 | |
| 881 | ALCAM levels | PROLV000078 | 2.76 | Protein levels | Hepatocyte | 193 | 3 | 13 | 31 | |
| 882 | PINLYP levels | PROLV001562 | 2.76 | Protein levels | Myeloid | 66 | 4 | 10 | 14 | |
| 883 | Urinary metabolite ratio | METAB000057 | 2.75 | Metabolites | Hepatocyte | 1 | 1 | 4 | 17 | |
| 884 | APP/CD40LG ratio | PRORT000122 | 2.74 | Protein ratios | Hematopoietic progenitor | 0 | 4 | 13 | 32 | |
| 885 | Gastric ulcer | GASTR000048 | 2.74 | Gastrointestinal | Lymphocyte | 3 | 1 | 7 | 27 | |
| 886 | CILP levels | PROLV000436 | 2.74 | Protein levels | Myeloid | 47 | 5 | 12 | 21 | |
| 887 | MEGF9/MET ratio | PRORT001513 | 2.73 | Protein ratios | Hepatocyte | 46 | 1 | 5 | 7 | |
| 888 | Medication, diuretic | VASCU000038 | 2.73 | Vascular | Vascular | 21 | 1 | 5 | 16 | |
| 889 | Premature cardiac beat | CARDI000023 | 2.73 | Cardiac | Neural / glial | 0 | 3 | 12 | 20 | |
| 890 | AGRP/NPY ratio | PRORT000050 | 2.73 | Protein ratios | Hepatocyte | 28 | 1 | 9 | 10 | |
| 891 | Rosacea | DERMA000019 | 2.72 | Dermatologic | Lymphocyte | 37 | 2 | 14 | 19 | |
| 892 | NCAM2 levels | PROLV001378 | 2.72 | Protein levels | Myeloid | 33 | 3 | 7 | 17 | |
| 893 | IGFBP7 levels | PROLV001033 | 2.71 | Protein levels | Hepatocyte | 24 | 1 | 7 | 17 | |
| 894 | HYOU1/ROR1 ratio | PRORT001316 | 2.71 | Protein ratios | Hepatocyte | 41 | 1 | 6 | 6 | |
| 895 | NTF3 levels | PROLV001442 | 2.71 | Protein levels | Vascular | 1 | 3 | 8 | 14 | |
| 896 | Refractive errors | OPHTH000034 | 2.70 | Ophthalmic | Neural / glial | 133 | 1 | 6 | 9 | |
| 897 | PTPRK levels | PROLV001677 | 2.70 | Protein levels | Hepatocyte | 30 | 1 | 8 | 20 | |
| 898 | SDK2 levels | PROLV001800 | 2.70 | Protein levels | Myeloid | 29 | 3 | 14 | 24 | |
| 899 | Blood pressure, BP, diastolic | VASCU000009 | 2.70 | Vascular | Vascular | 1,488 | 3 | 6 | 10 | |
| 900 | EBV EA-D antibody | IMMUN000060 | 2.70 | Immunologic | Muscle / cardiac | 8 | 1 | 5 | 13 | |
| 901 | Cortical thickness | NIMAG000010 | 2.70 | Neuroimaging | Neural / glial | 39 | 3 | 7 | 20 | |
| 902 | CC2D1A/TMSB10 ratio | PRORT000330 | 2.69 | Protein ratios | Myeloid | 4 | 3 | 11 | 27 | |
| 903 | Infertility | REPRO000010 | 2.69 | Reproductive | Vascular | 0 | 0 | 2 | 9 | |
| 904 | Jaw relationship anomaly | DENTA000007 | 2.69 | Dental | Neural / glial | 0 | 1 | 5 | 12 | |
| 905 | CCL22/PDGFB ratio | PRORT000351 | 2.69 | Protein ratios | Hepatocyte | 7 | 3 | 15 | 43 | |
| 906 | Eye disorder, none | OPHTH000007 | 2.69 | Ophthalmic | Neural / glial | — | 4 | 14 | 11 | |
| 907 | CD46/SIAE ratio | PRORT000459 | 2.69 | Protein ratios | Vascular | 13 | 2 | 8 | 19 | |
| 908 | Gout | METBL000043 | 2.68 | Metabolic | Hepatocyte | 506 | 1 | 10 | 10 | |
| 909 | GORASP2 levels | PROLV000911 | 2.68 | Protein levels | Vascular | 13 | 2 | 7 | 27 | |
| 910 | Brain ventricle volume | NIMAG000016 | 2.67 | Neuroimaging | Stromal / connective | 27 | 1 | 2 | 13 | |
| 911 | CANT1/ROR1 ratio | PRORT000309 | 2.67 | Protein ratios | Hepatocyte | 3 | 1 | 9 | 25 | |
| 912 | CTHRC1 levels | PROLV000556 | 2.67 | Protein levels | Myeloid | 27 | 4 | 11 | 12 | |
| 913 | ANPEP/CXADR ratio | PRORT000100 | 2.67 | Protein ratios | Vascular | 11 | 3 | 12 | 10 | |
| 914 | F7/F9 ratio | PRORT001087 | 2.66 | Protein ratios | Hepatocyte | 55 | 1 | 12 | 14 | |
| 915 | Abdominal aortic calcification | VASCU000051 | 2.66 | Vascular | Vascular | 0 | 1 | 4 | 11 | |
| 916 | SPINT1 levels | PROLV001932 | 2.65 | Protein levels | Cutaneous epithelium | 74 | 0 | 5 | 11 | |
| 917 | HSPB1 levels | PROLV000997 | 2.64 | Protein levels | Platelet | 16 | 3 | 3 | 13 | |
| 918 | CXCL12/TIMP3 ratio | PRORT000821 | 2.64 | Protein ratios | Vascular | 21 | 2 | 6 | 10 | |
| 919 | GRPEL1 levels | PROLV000935 | 2.63 | Protein levels | Hepatocyte | 23 | 2 | 8 | 24 | |
| 920 | COMP/ITGAV ratio | PRORT000711 | 2.62 | Protein ratios | Myeloid | 58 | 3 | 11 | 18 | |
| 921 | MMP10 levels | PROLV001322 | 2.62 | Protein levels | Epithelial | 12 | 0 | 6 | 7 | |
| 922 | CA2/HMBS ratio | PRORT000275 | 2.62 | Protein ratios | Lymphocyte | 4 | 1 | 13 | 42 | |
| 923 | ALDH1A1/CA2 ratio | PRORT000077 | 2.62 | Protein ratios | Hepatocyte | 9 | 1 | 4 | 17 | |
| 924 | B4GALT1/SMOC2 ratio | PRORT000189 | 2.62 | Protein ratios | Myeloid | 7 | 2 | 6 | 18 | |
| 925 | Snoring | RESPI000036 | 2.61 | Respiratory | Neural / glial | 12 | 3 | 11 | 32 | |
| 926 | METAP2 levels | PROLV001304 | 2.61 | Protein levels | Stromal / connective | 8 | 5 | 13 | 36 | |
| 927 | Arterial stiffness | VASCU000050 | 2.61 | Vascular | Stromal / connective | 3 | 2 | 3 | 12 | |
| 928 | PTPN1/TDRKH ratio | PRORT001717 | 2.61 | Protein ratios | Granulosa cell | 1 | 2 | 5 | 7 | |
| 929 | GPNMB levels | PROLV000927 | 2.60 | Protein levels | Hepatocyte | 49 | 5 | 9 | 24 | |
| 930 | IGDCC4 levels | PROLV001024 | 2.60 | Protein levels | Myeloid | 46 | 4 | 11 | 16 | |
| 931 | Pyruvate | METAB000069 | 2.59 | Metabolites | Hematopoietic progenitor | 6 | 1 | 3 | 6 | |
| 932 | Amygdala volume | NIMAG000014 | 2.59 | Neuroimaging | Hepatocyte | 32 | 0 | 1 | 7 | |
| 933 | MET levels | PROLV001302 | 2.59 | Protein levels | Hepatocyte | 162 | 2 | 8 | 18 | |
| 934 | FIS1/PDGFB ratio | PRORT001150 | 2.58 | Protein ratios | Myeloid | 14 | 2 | 8 | 23 | |
| 935 | S100A14 levels | PROLV001769 | 2.58 | Protein levels | Hepatocyte | 25 | 3 | 11 | 21 | |
| 936 | Cutaneous haemangioma | DERMA000003 | 2.58 | Dermatologic | Myeloid | 1 | 1 | 7 | 12 | |
| 937 | Exotropia | OPHTH000022 | 2.57 | Ophthalmic | Myeloid | 6 | 1 | 8 | 7 | |
| 938 | Total lipids, HDL | LIPID000074 | 2.57 | Lipids | Hepatocyte | 1,723 | 3 | 8 | 19 | |
| 939 | AIDA levels | PROLV000067 | 2.57 | Protein levels | B / plasma cell | — | 2 | 5 | 25 | |
| 940 | IGFBP6/MFAP5 ratio | PRORT001336 | 2.56 | Protein ratios | Vascular | 0 | 2 | 11 | 19 | |
| 941 | CIAPIN1/SNAP29 ratio | PRORT000616 | 2.56 | Protein ratios | Hepatocyte | 2 | 2 | 7 | 21 | |
| 942 | PRKAR1A/SNAP23 ratio | PRORT001710 | 2.55 | Protein ratios | Hepatocyte | 4 | 3 | 18 | 38 | |
| 943 | Heme malignancy, Lymphoma | MALIG000044 | 2.54 | Malignancy | B / plasma cell | 27 | 2 | 6 | 28 | |
| 944 | CPXM2 levels | PROLV000512 | 2.54 | Protein levels | Muscle / cardiac | 0 | 2 | 4 | 14 | |
| 945 | FUT3 levels | PROLV000837 | 2.54 | Protein levels | Neural / glial | 2 | 2 | 5 | 17 | |
| 946 | Biliary cirrhosis | HPBIL000005 | 2.53 | Hepatopancreatobiliary | Salivary epithelium | — | 0 | 12 | 10 | |
| 947 | CFHR5 levels | PROLV000417 | 2.53 | Protein levels | Hepatocyte | 18 | 3 | 9 | 16 | |
| 948 | FLT1/TFPI2 ratio | PRORT001162 | 2.52 | Protein ratios | Myeloid | 3 | 5 | 11 | 21 | |
| 949 | NECTIN2/SPON2 ratio | PRORT001579 | 2.52 | Protein ratios | Hepatocyte | 17 | 1 | 5 | 10 | |
| 950 | GZMA/TNFRSF8 ratio | PRORT001262 | 2.51 | Protein ratios | Lymphocyte | 48 | 4 | 14 | 44 | |
| 951 | CLEC1B/VTA1 ratio | PRORT000653 | 2.51 | Protein ratios | Hepatocyte | 9 | 1 | 5 | 20 | |
| 952 | Heart rate variability | CARDI000022 | 2.51 | Cardiac | Muscle / cardiac | 10 | 2 | 4 | 15 | |
| 953 | TNFRSF12A levels | PROLV002062 | 2.51 | Protein levels | Epithelial | 11 | 0 | 7 | 6 | |
| 954 | Liver enzyme levels, ALT | HPBIL000013 | 2.51 | Hepatopancreatobiliary | Hepatocyte | 1,395 | 2 | 5 | 15 | |
| 955 | BCR/NFATC1 ratio | PRORT000228 | 2.51 | Protein ratios | Hematopoietic progenitor | 0 | 2 | 8 | 14 | |
| 956 | Body water mass | BCOMP000006 | 2.50 | Body composition | Stromal / connective | 324 | 5 | 10 | 21 | |
| 957 | ASGR1/DCBLD2 ratio | PRORT000147 | 2.50 | Protein ratios | Hepatocyte | 92 | 3 | 9 | 19 | |
| 958 | Cortical volume | NIMAG000022 | 2.50 | Neuroimaging | Stromal / connective | 22 | 0 | 0 | 0 | |
| 959 | DSG2 levels | PROLV000655 | 2.50 | Protein levels | Epithelial | 31 | 0 | 9 | 6 | |
| 960 | NIT1 levels | PROLV001407 | 2.49 | Protein levels | Muscle / cardiac | 10 | 3 | 8 | 29 | |
| 961 | PLAUR/TREM2 ratio | PRORT001680 | 2.49 | Protein ratios | Hepatocyte | 73 | 3 | 12 | 16 | |
| 962 | DCBLD2 levels | PROLV000600 | 2.49 | Protein levels | Hepatocyte | 264 | 3 | 13 | 20 | |
| 963 | GSR levels | PROLV000938 | 2.49 | Protein levels | Myeloid | 12 | 3 | 11 | 26 | |
| 964 | PRTFDC1 levels | PROLV001649 | 2.48 | Protein levels | Platelet | 28 | 3 | 11 | 12 | |
| 965 | Xenobiotic metabolites | METAB000080 | 2.48 | Metabolites | Hepatocyte | 26 | 1 | 3 | 11 | |
| 966 | Medication, renin-angiotensin system agent | VASCU000040 | 2.48 | Vascular | Vascular | 24 | 0 | 4 | 8 | |
| 967 | HYOU1/TGFBR3 ratio | PRORT001317 | 2.47 | Protein ratios | Hepatocyte | 27 | 2 | 8 | 23 | |
| 968 | FCRLB levels | PROLV000788 | 2.47 | Protein levels | B / plasma cell | 86 | 3 | 8 | 21 | |
| 969 | PDGFRA levels | PROLV001525 | 2.47 | Protein levels | Hepatocyte | 55 | 2 | 4 | 14 | |
| 970 | KIAA0040 levels | PROLV001136 | 2.46 | Protein levels | Stromal / connective | 0 | 2 | 8 | 14 | |
| 971 | BTN2A1/LILRB4 ratio | PRORT000258 | 2.46 | Protein ratios | Myeloid | 77 | 3 | 10 | 14 | |
| 972 | DKK1/VTA1 ratio | PRORT000906 | 2.46 | Protein ratios | Myeloid | 1 | 3 | 14 | 24 | |
| 973 | GLOD4/HSPA1A ratio | PRORT001218 | 2.45 | Protein ratios | Myeloid | 20 | 4 | 13 | 19 | |
| 974 | CDH1/CST3 ratio | PRORT000546 | 2.45 | Protein ratios | Hepatocyte | 11 | 1 | 7 | 16 | |
| 975 | MZB1/TNFRSF13B ratio | PRORT001568 | 2.45 | Protein ratios | B / plasma cell | 4 | 2 | 15 | 28 | |
| 976 | LCN2/S100A12 ratio | PRORT001444 | 2.45 | Protein ratios | Myeloid | 28 | 4 | 18 | 35 | |
| 977 | SEL1L levels | PROLV001802 | 2.44 | Protein levels | Myeloid | 0 | 1 | 3 | 5 | |
| 978 | C4BPB levels | PROLV000234 | 2.43 | Protein levels | Hepatocyte | 150 | 1 | 8 | 19 | |
| 979 | APRT/PSME1 ratio | PRORT000137 | 2.43 | Protein ratios | Lymphocyte | 0 | 2 | 10 | 33 | |
| 980 | BCAN/MOG ratio | PRORT000217 | 2.43 | Protein ratios | Myeloid | 5 | 1 | 6 | 12 | |
| 981 | PAM levels | PROLV001492 | 2.43 | Protein levels | Myeloid | 112 | 2 | 11 | 21 | |
| 982 | PPP1R14D levels | PROLV001615 | 2.43 | Protein levels | Lymphocyte | 15 | 2 | 14 | 33 | |
| 983 | Male-pattern baldness | DERMA000032 | 2.43 | Dermatologic | Stromal / connective | 74 | 0 | 4 | 6 | |
| 984 | PDCD6 levels | PROLV001518 | 2.42 | Protein levels | Muscle / cardiac | 54 | 3 | 13 | 24 | |
| 985 | PDCD1/TNFRSF8 ratio | PRORT001630 | 2.42 | Protein ratios | B / plasma cell | 33 | 3 | 17 | 35 | |
| 986 | IL3RA levels | PROLV001074 | 2.42 | Protein levels | Granulosa cell | 51 | 1 | 10 | 25 | |
| 987 | PECAM1 levels | PROLV001534 | 2.42 | Protein levels | Myeloid | 39 | 2 | 7 | 17 | |
| 988 | Organic acids | METAB000068 | 2.41 | Metabolites | Neural / glial | 3 | 0 | 1 | 8 | |
| 989 | Diffuse idiopathic skeletal hyperostosis | MSKEL000074 | 2.41 | Musculoskeletal | Hematopoietic progenitor | 1 | 2 | 6 | 16 | |
| 990 | Body size, birth | BMORP000017 | 2.41 | Body morphology | Vascular | 12 | 2 | 6 | 9 | |
| 991 | SNX15 levels | PROLV001911 | 2.40 | Protein levels | Lymphocyte | 12 | 5 | 20 | 50 | |
| 992 | Lipoprotein particles, HDL | LIPID000043 | 2.40 | Lipids | Hepatocyte | 1,830 | 3 | 8 | 19 | |
| 993 | MTIF3 levels | PROLV001348 | 2.39 | Protein levels | Myeloid | 3 | 2 | 7 | 13 | |
| 994 | CHAC2 levels | PROLV000422 | 2.39 | Protein levels | Vascular | 4 | 3 | 10 | 21 | |
| 995 | Cholesterol, HDL | LIPID000003 | 2.39 | Lipids | Hepatocyte | 4,625 | 3 | 8 | 17 | |
| 996 | Heme malignancy, Chronic lymphocytic leukaemia | MALIG000041 | 2.39 | Malignancy | B / plasma cell | 53 | 3 | 15 | 32 | |
| 997 | FKBPL levels | PROLV000812 | 2.39 | Protein levels | Vascular | 10 | 1 | 6 | 12 | |
| 998 | SEMA7A levels | PROLV001811 | 2.38 | Protein levels | Myeloid | 113 | 2 | 11 | 23 | |
| 999 | ENTPD5 levels | PROLV000713 | 2.38 | Protein levels | Myeloid | 111 | 3 | 8 | 15 | |
| 1000 | CD300LG/TNFRSF1A ratio | PRORT000436 | 2.37 | Protein ratios | Vascular | 40 | 2 | 8 | 11 |